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Abstract
Biomolecular interactions form the basis of all living organisms and their detailed
investigation on the molecular level is crucial to the understanding of complex biolog-
ical systems. With the advent of single-molecule (SM) techniques in response to the
growing interest in the molecular nature of interactions, a whole new layer of knowl-
edge has emerged. Hence, bulk-derived characteristics of molecular complexes need
to be complemented by more detailed information addressing individual molecules
and not only their statistical representatives. This way also interactions that are
transient, weak or less abundant in the population are considered. This work focuses
on the single-molecule elucidation of different types of biomolecular interactions -
from protein-ligand to protein-DNA, to protein-protein ones.
The focus of the presented research is on force measurements, considered both in an
absolute manner as well as in comparison to other reference interactions. Compar-
ative analysis is more informative in many cases in which a ranking of interactions
against each other is of interest rather than their absolute strengths. Several SM
techniques are explored and their complementarity in targeting specific aspects of
single-molecule accessibility is discussed.
I present a way to eliminate multiple events’ bias in AFM measurements of biotin-
streptavidin bond rupture. Despite numerous studies, available data regarding the
binding force of the complex are not fully consistent and contain a lot of open ques-
tions. Here, the introduced DNA tether provided an intrinsic fingerprint, thus ensur-
ing SM-accessibility. The same assay allowed to address the MeCP2-DNA binding,
thought to lead to DNA cross-linking and looping. We observed DNA clustering
upon addition of the protein and turned to magnetic tweezers to further analyse the
mechanism of MeCP2 action. This instance demonstrates the challenges in proper
experimental design in both techniques when it is desired to achieve a truly SM res-
olution not only in sensing but also in the behavior of the investigated system.
Finally, I characterized the GFP-Nanobody binding as an exemplary protein-antibody
interaction. The energy landscape of the complex was explored by the AFM. Inter-
estingly, the force measurements revealed several regimes related to various pulling
geometries, as well as force dependence on the type of GFP despite identical epitopes.
Then, multiplexed single-molecule measurements by means of Molecular Force Assay
demonstrated the usefulness of this pair as a reference in comparative studies.
In this thesis I show that even with dedicated techniques achieving SM resolution
may not be a straightforward task. Studying molecular systems often requires a
very individualized approach so that native-like conditions can be mimicked while
the focus is strictly confined to one molecule only. To sum up, we have designed
assays to analyze biomolecular interactions on the SM level and demonstrate how
to ensure SM resolution by making use of intrinsic features of biomolecules. The
presented work contributes to the expansion of the existing SM techniques in the
field of protein research and provides binding force data for the GFP-Nanobody
complex - a promising molecular reference.

Chapter 1
Introduction
1.1 Molecular interactions in living systems
Force underlies motion and thus drives biological processes. As living systems are de-
fined by biological pathways involving interacting molecules, understanding cellular
dynamics and structure is only feasible through detailed elucidation of the molecu-
lar mechanisms. Interactions in living systems occur in a spatially and temporally
regulated manner, therefore they should be studied in a physiological context. This
explains the need for meticulous identification and characterization of the relations
between their components. Numerous methods have been developed that provide
various parameters of interest when describing interactions on the molecular level.
These can be divided into three groups: classical (indirect) approaches, computer
modeling and Single-Molecule Force Spectroscopy.
1.1.1 Classical approaches to study molecular interactions
Biochemical methods aimed at detection and identification of interaction partners
include co-immunoprecipitation (Co-IP), Western blot analysis and affinity purifica-
tion. They all rely on the principle of ‘fishing’ the specific interaction partner out of
a solution (e.g. cellular lysate). A genetic yeast two-hybrid (Y2H) system is based on
co-expression of putative interaction partners as fusion proteins and reconstruction
of the transcription activator upon their binding. Due to its simplicity, low cost and
rapidness, Y2H is particularly popular for high throughput screening. Phage display
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is another example of an assay suitable for large library analysis, allowing for the
identification of high-affinity binders.
In addition, also biophysical techniques have been developed: Dynamic and Static
Light Scattering determine the size distribution of molecules in solution, Circular
Dichroism exploits the chiral nature of biomolecules, Isothermal Titration Calorime-
try provides binding affinity as well as thermodynamic parameters (enthalpy ∆H,
Gibbs energy change ∆E and entropy change ∆S). Microscale Thermophoresis pro-
vides binding affinities and kinetics derived from the observation of particle move-
ment in a temperature gradient. Surface Plasmon Resonance detects mass changes
upon analyte build-up on a biosensor with an immobilized ligand. Fluorescence-based
approaches depend on the labeling of molecules or their intrinsic fluorophores. Flu-
orescence Resonance Energy Transfer (FRET) - a non-radiant, distance-dependent
energy transfer is applicable particularly for smaller molecules. This length (size)
constraint does not apply to Fluorescence Correlation Spectroscopy or its two-channel
version - Fluorescence Cross-Correlation Spectroscopy. Both these techniques are ca-
pable of measurements inside living cells and determine binding stoichiometry and
binding constants. Fluorescence Polarization provides quantitative information on
molecular interactions as well as enzymatic activity. This method is based on reduced
mobility caused by molecules binding to form complexes.
Yet another possibility to map interaction networks is chemical cross-linking resulting
in covalently linked binding partners, which can then be subjected to further analysis
by Mass Spectroscopy.
Using a combination of the abovementioned techniques allows for - besides recreat-
ing interaction networks - the determination of parameters describing the affinity,
stoichiometry, energetics and kinetics of the interaction. A common weakness of all
these assays is that the conclusion is drawn based on averaging over a large number of
molecules. This indirect character results in transient or weak interactions being lost
or masked due to washing or simply scarcity. Yet even the statistically insignificant
events do play an important role in nature and so need to be considered.
1.1.2 Computer simulations
Theoretical approaches by means of computer modeling are of immense help in
gaining thorough understanding of the interactions. Detailed simulations remain,
however, laborious, time-consuming and computationally expensive. Computer sim-
ulations rely on structural data (X-ray or NMR) and utilize equations of motion
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to predict mechanical details of the particles’ dynamics. Due to limits in computa-
tional capacity, it is not possible to model laboratory or physiologically meaningful
timescales. Therefore, computer simulations are best exploited as complementary to
experimental studies.
1.1.3 Single-Molecule Force Spectroscopy
Studying forces on the single-molecule level is crucial for an in-depth understanding
of the mechanisms steering the living systems. A range of techniques has been
developed to perform single-molecule force spectroscopy, most widespread ones being:
Atomic Force Microscopy, Magnetic Tweezers, Optical Tweezers and Biomembrane
Force Probe. The single-molecule approach reveals features otherwise out of reach for
ensemble-averaged bulk measurements, such as the mechanical stability of proteins
or receptor-ligand complexes, as well as rare events. Currently, sensitivities down to
single angstrom (Å) in length and a femtonewton (fN) in force can be achieved.
Single-molecule techniques exploited in this work are described below.
Atomic Force Microscopy
Invented in 1986, Atomic Force Microscope (AFM) [Binnig et al., 1986] is one of the
tools of the Scanning Probe Microscopy family. The instrument utilizes a microstruc-
tured probe - a cantilever with a sharp tip at its end - controlled with a piezoelement
to scan the surface under investigation, as schematically depicted in Fig. 1.
Considering the movement of the tip over the sample, AFM can operate in con-
tact, non-contact or tapping (intermittent contact) mode. Initially conceived as a
conductvity-independent imaging technique, soon after its introduction the AFM
became a basic tool in single-molecule biophysics, proving successful in both un-
folding as well as unbinding studies of biomolecules. The following description of
the technique focuses on the use of the AFM for force spectroscopy. The central
part of the instrument is a cantilever oscillating vertically over the sample surface.
The movement of the cantilever is optically monitored and a force-distance curve
is generated after each approach-retract cycle. The cantilever acts as a soft spring
and exerted forces cause it to bend. In a typical single-molecule rupture experiment
interacting molecules of interest are attached to the cantilever and substrate surface
respectively. As the cantilever is brought in contact with the surface, the complex
forms and upon cantilever retraction it is stretched until rupture, represented as a
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Figure 1.1: Schematic of the principle of AFM Force Spectroscopy. The biomolecule
is tethered between the cantilever tip and the surface resting on a piezo-stage. A
laser beam is projected onto the top of the cantilever and reflected off it to reach
the photodetector. Upon piezostage movement in the z-direction, the molecule is
stretched and exerts force on the cantilever, which bends. Deflection of the cantilever
changes the position of the laser spot on the detector. (Fig. source: [Oberhauser et
al., 2001] copyright 2001 National Academy of Sciences.)
sharp peak in the force-distance graph. Repeating the cycle for a couple of hundred
times yields a Gaussian distribution of measured forces centered around the most
probable rupture force.
In unfolding studies, molecules are probed in a similar manner, the difference being
that a series of peaks representing domains or fragments unfolding precedes the
final rupture peak. Transforming the recorded force-distance trace into the force-
contour length one allows for mapping the unfolding pattern to the investigated
structure.
Molecular Force Assay
Molecular Force Assay (MFA) is a multiplexed differential single-molecule technique
developed to test binding strength of a complex relative to that of a known refer-
ence. In other words, a previously characterized molecular bond is employed as a
force transducer. MFA does not determine the absolute rupture force value, rather
the mutual relation of the two interactions, which is often more meaningful when
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explaining the mechanistic aspects of a system. In MFA, a single measurement cycle
provides statistics for the evaluation of the investigated interactions in the order of
109 as this many force balances are screened [Albrecht et al., 2003].
The experiment is conducted using a custom-built instrument based on an inverted
epifluorescence microscope and a piezo-controlled head above it. The force balances
are built by stepwise deposition of the molecules on a glass slide. Covalent immo-
bilization of the balance to the slide and specific pairing within the balance results
in two breakable bonds in series. The actual principle of the balance is exercised
by bringing the top surface in contact with the functionalized glass slide and then
retracting it. The top surface constitutes an elastomer stamp with 16 pads (1 mm2
each) corresponding to the 16 spots on the sample slide. Streptavidin is covalently
bound to the pads and upon contacting the lower surface, binds the biotinylated ends
of the force balances. Retraction of the stamp exposes all assembled force balances
to load and in consequence in each of them either the test bond or the reference bond
ruptures. The position of the middle strand after the stamp removal indicates which
was the case. In its initial form the technique utilizes oligomeric double-stranded
DNA pulled against each other (see Fig. 1.2).
Shorter bottom and top single strands are cross-linked by one longer strand creating
two double-stranded fragments. Fluorescent labels attached to the middle (Cy5)
and top (Cy3) DNA strands allow for coupling efficiency determination, as correct
assembly of a single balance brings the two fluorophores close together, creating a
FRET pair.
Fluorescence scans before and after the probing of the force balances allow for ratio
calculation of both the RED signal (Cy5 channel), giving the proportion of intact
bottom bonds:
RatioRED =
REDfinal
REDinitial
(1.1)
and the FRET signal, giving the proportion of intact top bonds:
RatioFRET =
FRETfinal
FRETinitial
(1.2)
Now it is crucial to correct for the force balances that failed to couple to streptavidin
on the stamp and thus were not probed. Therefore, the coupling efficiency (CE) is
determined as:
CE = 1−RatioFRET (1.3)
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Figure 1.2: Schematic visualization of Molecular Force Balance. Upper DNA strand
is labeled with Cy3 (green) and middle one with Cy5 (red).
Based on that, the ratio of broken test bonds as compared to reference bonds is
expressed as the normalized fluorescence (NF ):
NF =
(RatioRED −RatioFRET )
CE
(1.4)
NF equals 0.5 for test and reference bonds of the same strength, since then any
of them ruptures with a 50 % chance. Difference in bond strength skews the NF
accordingly, while it always takes values from 0 to 1.
Magnetic tweezers
The idea of magnetic tweezers (MT) was first demonstrated by Crick and Hughes in
1950 [Crick and Hughes, 1950]. Here, a biological polymer of interest (DNA, RNA,
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structures thereof or a nucleosome fiber) is tethered between the flowcell bottom and
a micron-sized superparamagnetic bead as depicted in Fig. 1.3. In the most common
experimental design, the flowcell is placed between an inverted microscope and a
pair of magnets, the height of which can be regulated. The magnetic field induces
a magnetic moment in the bead and the bead experiences a force proportional to
the gradient of the field, thus stretching the tether. The acting force can be inferred
from vibrations in the x-y plane, while the z-position of the bead (relative to a
surface-bound reference bead) gives the so called tether contour length. Since the
characteristic length scale over which the field gradient varies is large (typically of
the order of 1 mm), the exerted force can be considered constant over the distance
penetrated by the bead. Force range from a few pN to about 100 pN can be covered
by Magnetic Tweezers, tunable by varying bead size, gap between the magnets and
their distance from the flowcell.
Y
YYY
YY YY
N
S
S
N
Figure 1.3: Schematic of magnetic tweezers. The biopolymer is spread between
sample surface and a superparamagnetic bead, which can be manipulated in the
field gradient.
Interestingly, magnetic tweezers offer parallel single molecule tracking, unachievable
by other SM techniques. The throughput of multiplex measurements (involving
many tethers manipulated at the same time) depends on the number of trackable
beads in the field of view of the camera. With optimized surface chemistry, to date
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double-digit numbers of tethers have been successfully scanned in parallel. For larger
numbers of tracked beads online calculation of bead positions becomes cumbersome
and can be replaced by post-measurement data analysis to make the measurement
feasible.
Theoretical background of magnetic tweezers
Force exerted on a bead can be determined based on its lateral fluctuations and
extensions of the tether:
F =
1
2
∇(~m · ~B) (1.5)
where m is the induced magnetic moment of the bead in the external magnetic field
~B.
The total potential energy of the tether is composed of mechanical energy stored in
the nucleic acid (dependent on its end-to-end extension l) and a magnetic compo-
nent:
Ep = ENA + Em = A(l)− Fz (1.6)
where F denotes magnetic force acting on the bead and z - tether extension.
Due to Brownian motion, the bead constantly fluctuates. Therefore its potential
energy can be expressed by:
〈Ep〉 = 1
2
F
l
〈δx2〉 (1.7)
where F
l
is the effective trap stiffness in the x direction (i.e. direction of the field)
and
var〈δx〉 ≡ 〈δx2〉 − 〈δx〉2 = 〈δx2〉 (1.8)
(x - bead position in the direction of the field).
Since, by the equipartition theorem, the energy of one degree of freedom equals
1
2
kBT ,
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F =
kBT l
〈δx2〉 (1.9)
At forces higher than ∼1 pN the above formula results in a systematic error [Vilfan
et al., 2009], that can be corrected for by Allan variance (AV), which is half of
the ensemble-averaged variance of the difference between two consecutive samples of
position, where each sample is itself a local average of the probe position [Lansdorp
and Saleh, 2012]:
σ(t) =
1
2
〈(x¯τ,j+1 − x¯τ,j)2〉 (1.10)
Allan variance is a time-domain analysis, hence it does not entail any aliasing or
spectral leakage [Lansdorp and Saleh, 2012]. It assumes a finite averaging time,
which matches the video tracking instrument function, so no additional corrections
of instrumental response are necessary.
Other single-molecule techniques
Biomembrane Force Probe
Introduced in 1995, Biomembrane Force Probe [Evans et al., 1995], comprises a
microbead attached to a cell membrane (or synthetic lipid bilayer) spread over the
aperture of a glass micropipette. The bead serves to probe the investigated surface.
Here, the stiffness of the force transducer can be regulated by changing the suction
pressure of the membrane and force sensitivity below 0.1 pN can be achieved.
Laser Optical Tweezers
In Optical Tweezers, also referred to as optical trap, a tightly focused laser beam is
used to spatially confine a dielectric particle. The particle is polarized by the optical
field and interacts with the steep gradient near the focus. The steepness of the
gradient, the power of the laser and the polarisability of the particle all determine
the stiffness of the trap, referred to as spring constant. The broad size range of
trappable molecules (from ~20 nm up to several µm) makes it possible to trap single
cellular organelles as well as whole cells or microstructured beads.
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1.2 Bell-Evans model of bond dissociation
As described above, different measurement methods describe the same interaction
with various parameters, which - although not equivalent - are related to each other.
Hence, studying the system far from its equilibrium makes it feasible to derive equi-
librium constants. A molecular bond is characterized by a dissociation rate koff
determining its lifetime toff = 1koff , that is the time necessary for it to break spon-
taneously.
Breaking the bond requires the system to overcome an energy barrier, the height of
which describes the bond strength. A molecular complex is confined to an energy
well, the depth of which is given by:
∆G0
kBT
= lnKD − ln55 (1.11)
where ∆G0 is the binding free energy, KD the dissociation constant in mole fraction
and kBT sets the energy scale. The term −ln55 is a result of converting the dissoci-
ation constant into a unitless value by normalizing to molarity of H2O (55 M) [Paul,
2003].
There may also exist an additional activation barrier separating the bound and un-
bound states of the system. Bond dissociation is possible owing to the thermal energy
of the system, contributing transient impulses of force. Also under external load it
is still the thermal energy that is responsible for bond breaking but in this case it is
aided by the applied force. The energy landscape describes the complex by a set of
energetic minima separated by energy barriers that need to be overcome in order to
dissociate the molecules. External force tilts the energy landscape, diminishing the
barriers as shown in Fig. 1.4.
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Figure 1.4: External force tilts the energy landscape lowering the energy barriers to
dissociation. Black: reaction pathway without force; blue: reaction pathway under
force.
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Kinetics of a system subjected to external load (external force) is described by dy-
namic spectrum of rupture forces depending on the loading rate. The longer the
force is applied, the more it affects the barrier; hence the observed dependence of
rupture force on loading rate (force/time). The Bell-Evans model describes the most
probable rupture force F ∗ as a function of temperature T and loading rate F˙ :
F ∗ =
kBT
∆x
ln
F˙∆x
kBT · koff (1.12)
where ∆x denotes the position of the energy barrier and kBT thermal energy of the
complex.
1.3 Biopolymers
On the molecular level, living systems are assemblies of molecules organized into
complexes and organelles. A great deal of biomolecules falls into the category of
polymers, prominent examples being nucleic acids and proteins. Thus, studying their
mechanics requires appropriate physical models describing molecules’ behavior.
1.3.1 Polymer elasticity models
Polymers are long, linear chains of repeated subunits. Proteins are folded polypep-
tides composed of amino acids, while building blocks of DNA or RNA are nucleotides.
Despite the vast diversity of the biopolymer world, these macromolecules share com-
mon mechanical properties stemming from their similar overall architectural concept.
Semi-flexible polymers are, to a good approximation, described by the Freely Jointed
Chain (FJC) and Wormlike Chain (WLC) models.
Freely Jointed Chain
In the FJC model, the polymer is perceived as a chain of N stiff segments of define
length l known as Kuhn length (double the persistence length), characteristic for the
polymer. Thus the total length L of the polymer chain is:
L = Nl (1.13)
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The rotational freedom of the chain is restricted only to the joints. The theoretical
Kuhn length not necessarily resembles the size of molecular segments of the polymer,
for instance the best fit of FJC for a typical dsDNA molecule gives l of about 100
nm compared to the 0.34 nm contour length per basepair.
Wormlike Chain
More complex is the Wormlike Chain (WLC) model [Marko and Siggia, 1995], which
assumes a polymer to behave like a fluctuating, isotropic and linearly elastic rod. It
can be viewed as the limiting case of FJC, with Kuhn length approaching zero.
FA
kBT
=
z
L
+
1
4(1− z/L)2 −
1
4
(1.14)
where F is the applied external force, A the bending stiffness of the molecule, kB the
Boltzmann’s constant, T the absolute temperature, z the extension of the molecule
and L the total molecular contour length. The WLC model provides a good fit for
force-extension traces of many biopolymers, like double-stranded DNA or RNA, and
polypeptides.
1.3.2 Stretching the polymer of DNA: B-S transition
For a long time the mechanics of DNA under load remained vaguely understood with
several competing models trying to elucidate the nature of this biopolymer’s over-
stretching. Relaxed double-stranded DNA (dsDNA) molecule has a form of β-helix
described in the seminal work by Watson and Crick [Watson and Crick, 1953]. Under
external load, B-DNA first reaches its contour length of 3.4 nm/bp. Upon further
stretching, the molecule elongates by 70 % assuming an S-form, with maintained -
at least partially - double-stranded structure. This constitutes a transient form on
the way to full mechanical denaturation (melting), observed at several hundred pN
resulting in two separate strands. Depending on the attachment geometry, the B-S
transition occurs at 65 pN (for dsDNA anchored at opposite ends) or 110 pN (when
both ends of the same strand are probed) and in both cases manifests itself with a
plateau in a force-distance trace (Fig. 1.5).
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Figure 1.5: Force-extension curve of double-stranded λ-DNA. While retracting the
cantilever from the surface with a velocity of 16 µm/s the double-stranded λ-DNA is
stretched. At a force between 65 and 70 pN the well-known highly cooperative B-S
transition is observed. During this transition the DNA duplex lengthens by a factor
of 1.7. After this transition the force increases to a value of ~170 pN, at which the
DNA finally ruptures. Adapted from [Morfill et al., 2007]
1.4 Studying biological interactions
1.4.1 Green Fluorescent Protein
Green Fluorescent Protein (GFP) was first mentioned by [Shimomura et al., 1962]
but it was not until three decades later when it was cloned by Prasher [Prasher et
al., 1992], which resulted in an explosion of its popularity due to the unusual ability
of this protein to generate visible light. Understanding the mechanisms driving
GFP fluorescence led to an immediate breakthrough in biological sciences, honored
with the Nobel Prize in 1998. Employed as a molecular tag, GFP revolutionized
cell biology, facilitating in vivo imaging without any disturbance to the visualized
cells.
The bimodal excitation (absorbance) spectrum of the wtGFP displays the main peak
at 395 nm and a less pronounced one at 475 nm [Chalfie, 1995]. The major peak cor-
responds to the chromophore in the anionic (deprotonated) state whereas the minor
one - to the neutral state. In its natural environment, wtGFP converts the energy
transferred from calcium-dependent aequorin into green fluorescence [Prasher et al.,
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1992]. In laboratory conditions, GFP excitation is achieved by direct illumination
with UV or blue light. Rather poor folding efficiency of the wtGFP variant prompted
the development of a humanized, enhanced form of GFP (eGFP) [Zhang et al., 1996].
The introduced mutations in the chromophore (F64L, S65T) made the protein 35
times brighter than its wild-type predecessor. EGFP features the two mentioned
absorbance peaks but the one for higher wavelength becomes predominant (and also
slightly red-shifted to 488 nm). Besides these two most common representatives of
the GFP family, a vast number of other color variants exists, spanning most of the
visible light spectrum. This opens up extensive multiple-color imaging possibilities as
well as applications exploiting FRET. Yet another interesting example of engineered
GFP is a variant characterized by improved folding kinetics useful in expression when
fused to poorly folding proteins - called superfolder GFP (sfGFP) [Pédelacq et al.,
2006].
Green fluorescent proteins can also be isolated from species other than Aequorea, like
e.g. a hydroid Obelia or a sea pansy Renilla [Morin and Hastings, 1971]. Other than
Aequorea GFP, only the one produced by Renilla has been biochemically well charac-
terized and despite the apparently identical chromophore, it differs from the former
in amino-acid sequence, physical parameters like extinction coefficient, pH-tolerance
and tendency to dimerize [Ward et al., 1980]. This explains the unquestionable
domination of the Aequorea-derived GFP and variants thereof in research use.
Full length wtGFP comprises 238 amino acids, which fold into an eleven-stranded
β-barrel closed on one end by a short α-helix. The molecule is about 2.4 nm in
diameter and 4.2 nm long. Both N- and C-termini protrude form the same side of
the barrel and another α-helix runs axially through it. The chromophore is formed by
three adjacent amino acids (residues 65-67) within this helix, through a cyclization
process involving molecular oxygen.
The mechanical stability of GFP has been investigated by Dietz and Rief [Dietz and
Rief, 2004]. They observed the β-barrel unfolding through two intermediate states:
by first losing the N-terminal seven-residue-long α-helix at about 35 pN, followed by
removal of one of the terminal β-strands at higher forces, before the whole structural
integrity is lost at over 100 pN.
1.4.2 Recombinant binders
Studying biological interactions requires specific probes for identification, visualiza-
tion and purification, both inside the living cells as well as in vitro. Thus, versatile
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binders are needed, which are not only easy to produce but also tailored to specific
needs of a particular approach. Revolutionary hybridoma technology introduced by
Koehler and Milstein [Kohler and Milstein, 1975] brought research in the field of
antibodies to a thrive. These are, however, clearly of limited use due to expensive
production, low tissue penetration, complex architecture and bivalent or multivalent
mode of action as well as in many cases - patent issues. Several alternative strategies
are the subject of ongoing efforts, aimed at overcoming the obstacles beyond reach for
the traditional antibody-based approaches. These can be classified into two groups:
antibody-derivatives and non-antibody binders. Small binders share a number of
advantages over traditional antibodies, such as ease and reduced cost of production,
more efficient tissue penetration and fast renal clearance. Possible therapeutic use
of any type of small protein binders relies either on the unmodified versions or on
their conjugates (or fusion proteins).
Antibody mimetics
The class of non-antibody binders, also referred to as antibody mimetics, features a
number of scaffolds. One example is a 10 kDa fibronectin protein fold based on human
fibronectin type III domain (FN3). The FN3 forms a β-sandwich structure similar to
that of immunoglobulin domains. This inspired its use as a scaffold for engineering
novel binding proteins referred to as monobodies or Adnectins [Koide et al., 1998].
Twice as large - yet still in the range of small binders - are 20 kDa anticalins derived
from the family of extracellular proteins, lipocalins, responsible mainly for transport
and storage of physiologically significant molecules [Flower, 1996]. Lipocalins share
a structural motif of an eight-stranded β-barrel enclosing an internal ligand-binding
site, particularly suited for small, hydrophobic molecules (but types of ligands vary
throughout the family). Domain of protein A of Staphylococcus aureus has in turn
become a template for affibodies, with α-helical structure and molecular weight of
only 6.5 kDa [Nord et al., 1996].
Designed ankyrin repeat proteins (DARPins) [Amstutz et al., 2006; Binz et al., 2003]
constitute another novel class of binders which may outperform monoclonal anti-
bodies. These small - typically 14-21 kDa - single domain proteins, characterized
by high temperature stability (midpoint denaturation at 65-95 °C) and no aggre-
gation tendency are modular molecules usually composed of 4-6 segments: amino-
and carboxy-terminal cap and 2-4 inner segments. A single segment is made of 33
amino-acids (3.5 kDa), 7 of which are variable. Libraries based on just two variable
segments reach diversities over 1014 [Stumpp et al., 2008]. Ankyrin proteins natu-
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rally occur in erythrocytes and belong to the most abundant proteins encoded in the
human genome. Therefore, DARPin drugs are expected to be well tolerated by the
immune system [Vogel et al., 2007; Stumpp et al., 2008]. Their natural function is
recognition and binding of large epitopes. In many organisms the immune system
relies on repeat proteins. Free of intrinsic cysteines, DARPins can be easily modified
by introduction of a thiol group for convenient site-specific chemical coupling.
Antibody-derived binders
Antibodies (also referred to as immunoglobulins) are the active agents of the verte-
brate immune system responsible for recognition, binding and inactivating foreign
agents in the organism. Among the five classes of antibodies (IgG, IgM, IgA, IgD and
IgE), IgG are the most abundant and play the key role both in their natural habitat
as well as in biotechnological applications. An IgG molecule is a large, 150 kDa,
glycoprotein formed by two heavy and two light sugar-modified polypeptide chains
kept together by disulphide bridges and hydrophobic interactions on their interface.
Parts of one heavy and one light chain contribute to the formation of each of the two
antibody binding sites on the termini of the Y-shaped monomer. Hence, isolating
this domain was the most straightforward approach to create a small binder. The
resultant molecule is Fab (Fragment, antigen-binding) with a molecular weight of
50 kDa, composed of one constant and one variable domain of the heavy and light
chain of the antibody. Thermal stability of such molecule is weak, since within the
antigen-binding site there is no covalent link between the two chains.
Nanobodies
The discovery of heavy-chain-only antibodies (HCAbs) in camelids [Hamers-Casterman
et al., 1993] inspired completely new approaches in antibody engineering. Devoid of
light chains, HCAbs recognize their antigens using single protein domains; unlike
their conventional counterparts, which need parts of both heavy and light chain to
bind the epitope. Derived from HCAbs, so-called Nanobodies (Nbs) constitute the
smallest functional antigen-binding domain (see Fig. 1.6). Their average molecular
mass of about 15 kDa makes them ten times smaller than typical antibodies, yet
they remain competitive in their binding affinity and specificity. Nanobodies can be
raised against a desired antigen, easily cloned and expressed in heterologous hosts,
including bacteria [Arbabi Ghahroudi et al., 1997]. Interestingly, they combine the
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advantages of conventional antibodies with greatly improved tissue permeability ow-
ing to their reduced size and increased hydrophilicity [Muyldermans et al., 1994].
Nanobodies show a high degree of identity with human type 3 VH domains and
humanization strategies have been proposed [Vincke et al., 2009; Vaneycken et al.,
2010]. Therefore, it is not surprising that nanobodies were considered potent agents
in therapeutics and immunodiagnostic methods early on.
heavy chains
light chains
a b c
Figure 1.6: Schematic depiction of conventional antibody (a), heavy-chain-only an-
tibody (b) and Nanobody (c). Constant regions depicted in dark and light blue,
variable regions in red and orange.
Nanobodies are versatile reagents that are useful in a broad variety of applica-
tions. Of particular interest is the use of Nanobodies in in vivo imaging techniques
[Chakravarty et al., 2014; Herce et al., 2013; Goethals et al., 2014; Gainkam et
al., 2008; Vaneycken et al., 2011; De Groeve et al., 2010; Rothbauer et al., 2006].
Noninvasive (and repeatable) visualization is for example important when screening
the progress of a disease. Here, the Nanobodies’ small size and lack of adverse ef-
fects help bypass the limitations typical of conventional antibodies. In recent years,
Nanobodies have proven successful in therapy [Vandenbroucke et al., 2009; Overbeke
et al., 2014] and their bispecific derivatives are expected to aid in tumor treatment
by cross-linking otherwise unrelated antigens [Els Conrath et al., 2001; Hmila et al.,
2010]. Medical uses beyond oncology [Cortez-Retamozo et al., 2004; D’Huyvetter
et al., 2012; Altintas et al., 2012] include monitoring arthritis [Zheng et al., 2014],
atherosclerosis [Broisat et al., 2012] and other inflammatory diseases [Baral et al.,
2006; Stijlemans et al., 2011].
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1.5 Epigenetic DNA modifications
Life relies on genetic information passed from generation to generation by means of
a four-letter genetic code. The central dogma of molecular biology (illustrated in
Fig. 1.7) explains how genes, encoding proteins, shape living organisms. But genes
constitute only a part of the final picture. In its native form, DNA is rarely a bare
string of nucleotides. Rather, it is subject to epigenetic modifications, turning genes
on and off and regulating the functioning of the genome in each individual cell.
Figure 1.7: Schematic illustration of the central dogma of molecular biology explain-
ing the directed flow of information leading from DNA to RNA to protein.
The term "epigenetics" refers to genome alterations not involving changes in DNA
sequence. These mechanisms are crucial for X chromosome inactivation as well as
for the course of cell differentiation [Holliday, 2006]. DNA methylation is the most
abundant epigenetic mark in eukaryotes and occurs exclusively at cytosine residues,
predominantly at CpG dinucleotides [Bird, 1986]. In mammals 60-90 % of CpGs are
methylated with the exception of CpG islands, mostly found in gene promoter regions
and generally left unmethylated. Introduction and maintenance of the methyl tags
is accomplished by methyltransferases: de novo methyltransferases DNMT3a and
DNMT3b, modifying previously unmethylated DNA, and maintenance DNMT1 re-
sponsible for copying methylation pattern onto the nascent strand during replication
[Jeltsch, 2006]. The latter, however, has been shown to also posses de novo methyla-
tion activity [Fatemi et al., 2002; Pradhan et al., 1999]. On the other hand there are
enzymes specialized in reading the epigenetic information: the MBD (Methyl-DNA
Binding Domain) family [Hendrich and Bird, 1998], the Kaiso family [Daniel and
Reynolds, 1999; Filion et al., 2006] and the Uhrf family [Hopfner et al., 2000; Bronner
et al., 2007]. Yet another group of epigenetically-sensitive DNA binders constitute
the family of Tet (ten-eleven translocation) proteins responsible for 5-methylcytosine
(5mC) conversion to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and
5-carboxycytosine (5caC) [Mohr et al., 2010].
It is epigenetics that makes cells of a single organism, sharing the same genetic ma-
terial so different as to be parts of completely unrelated tissues and specialize in
totally distant functions. Genomes of various organisms display different levels of
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dependence on methylation and even within a single organism significant changes in
methylation pattern occur throughout its life, in relation to developmental stages and
environmental factors [Bogdanović and Veenstra, 2009]. Similar mechanisms underlie
slight differences in the phenotypes of monozygous twins, a phenomenon confirmed
by extensive research [Fraga et al., 2005; Singh et al., 2002; Petronis, 2006; Bell
and Spector, 2011]. Epigenetic discrepancies in otherwise genetically identical twins
were found to accumulate with age and reflect factors such as exposure to toxins
(e.g. smoking), medical history, diet, stress or physical activity. Changes in the
epigenome also affect the CpGs within promoter regions, potentially affecting gene
expression. Another interesting example of epigenetic regulation through methyla-
tion is the social structure organization in the honeybee, in which queens and worker
bees develop sharing the same genetic material and differing only in the type of food
received from early on [Barchuk et al., 2007; Colhoun and Smith, 1960].
1.5.1 Methylcytosine binding proteins
Five proteins: MBD1, MBD2, MBD3 and MBD4 as well as MeCP2 form the MBD
family [Hendrich and Bird, 1998]. Their common feature is the domain responsible
for specific binding of methylated CpG dinucleotide - the MBD domain. Apart from
mammalian MBD3 and the long form of amphibian MBD3 (MBD3 LF), all these
proteins specifically recognize and preferentially bind methylated over unmethylated
DNA. Lack of this specificity in MBD3 is a result of insertion in its MBD region
[Wade et al., 1999]. Additionally, MBD1 can also bind DNA via its CxxC3 zinc-finger
domain [Jørgensen et al., 2004]. The preference for methylated over unmethylated
DNA is three- to tenfold throughout the family and may as well be influenced by the
nucleotide context.
1.5.2 Methylated-CpG binding Protein 2
The multifunctional mammalian protein MeCP2 (Methyl-CpG binding Protein 2),
first described by [Lewis et al., 1992], is involved in transcription activation and
repression, RNA processing and chromatin organization. It is expressed in all tissues
and displays extremely high abundance in neuronal chromatin. Mutations in MeCP2
are associated with Rett Syndrome (RTT) and autism spectrum disorders [Amir et
al., 1999], as well as certain cancers (reviewed in [Parry and Clarke, 2011]). MeCP2
localizes to both promoter and intergenic regions in the nuclei of neuronal cells [Yasui
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et al., 2007]. Deviations from its normal expression level have drastic effects on proper
brain function.
Intact MeCP2 has a theoretical molecular weight of 53 kDa but during electrophoretic
analysis it co-migrates with markers of 81 kDa [Nan et al., 1993]. Full length protein
is composed of 486 amino acids, among which 60 % are unstructured, 35 % folded
into β-strand or turn and 5 % α-helix [Adams et al., 2007; Ghosh et al., 2008].
The key domain of MeCP2, responsible for specific binding to methylated CpG sites
Methylated-CpG Binding Domain (MBD) spans amino acid positions 78-162 [Nan
et al., 1993], accounts for 17 % of its full length and is one of the few regions with
organized secondary structure. The MBD core consists of an α/β sandwich and
recognizes the hydration pattern of methylated CpG dinucleotide rather than the
methyl group per se [Ho et al., 2008].
To date, several other domains have been identified; these include AT-hooks re-
sponsible for DNA-methylation-independent chromatin binding [Baker et al., 2013],
the DNA-binding domain and binary chromatin-binding sites [Nikitina et al., 2007],
protein-protein-interacting regions present within these domains, including a dimeriz-
ing domain as well as a WW domain-binding region (WDR) [Buschdorf and Strätling,
2004] also mediating interactions between proteins. Thanks to the wide attention
MeCP2 has experienced in the past years its structural composition and biochem-
istry has been well described, yet the mechanism of its binding to DNA still lacks a
detailed understanding.
1.6 Biotin-streptavidin bond
Streptavidin (SA), first described by [Chaiet and Wolf, 1964], is a 60 kDa protein
composed of four identical subunits. It is isolated from soil bacteria Streptomyces
avidinii. The tetramer assembles as a dimer of dimers, exposing four β-barell-shaped
binding pockets for its ligand - biotin. Each β-barrel is composed of eight antiparallel
β-strands [Kurzban et al., 1990]. A complex of single biotin with streptavidin is
stabilized by the residues of the beta-barrel of one subunit and a single tryptophan
(Trp120) of a neighboring one, which upon binding moves towards the binding site
inducing structural change of the whole protein [Weber et al., 1989]. Rearrangement
of one surface-exposed loop of streptavidin (closing the pocket) plays an additional
role in the complex formation [Freitag et al., 1997]. The unusual strength with
which streptavidin binds its ligand relies mainly on hydrophobic and van der Waals
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interactions, aided by seven hydrogen bonds, five of which are buried deep in the
pocket and protected from competing solvent molecules.
The unusually low Kd of 10−15 M [Chaiet and Wolf, 1964; Green, 1975] places the
biotin-streptavidin complex among the strongest non-covalent ones in nature, in-
tensely studied as a model receptor-ligand pair. The fact that streptavidin readily
accommodates not only free but also derivatized biotin has lead to the common
use of this system in protein purification and biomolecules immobilization. Surface-
exposed lysine side chains provide primary amines facilitating convenient chemical
modifications of the protein. Other members of the biotin-binding protein family
include hen egg avidin - a glycoprotein which shares just 38 % of sequence identity
with SA (yet displays high structural similarity), and its deglycosylated version -
neutravidin (NA) [Marttila et al., 2000]. All these proteins share the high Kd but
differ in pI values (10 for avidin, ±7 for SA, 6.3 for NA), which plays a role in surface
interactions with solid support or other molecules. Monovalent streptavidin has also
been reported, offering similar affinity to biotin as the wild-type form [Howarth et
al., 2006].
Streptavidin-biotin interaction has received a lot of attention over the past years.
Available data is, however, not quite consistent. Many attempts to determine binding
strength of the complex resulted in force values ranging from 120 pN to even 450 pN
[Yuan et al., 2000; Stevens et al., 2002] and not always all the interesting parameters
are provided. Although the now growing in prominence cohesin-dockerin system
withstands much higher forces - in the order of 700 pN - the biotin-streptavidin pair
still remains one of the most popular complexes used for anchoring biomolecules to
solid support.
1.7 Aims of the work
Molecular interactions shape the living systems and only through their detailed elu-
cidation are we able to fully understand the mechanisms of life. Currently available
single-molecule techniques are designed to ensure enhanced precision and sensitivity.
The objective of this work is to provide insight into different types of biomolecular
complexes. Using the advantages of diverse single-molecule techniques, examples of
protein-ligand, protein-DNA and protein-protein interactions are characterized in a
manner unavailable for classical approaches.
First, I aimed at demonstrating the usefulness of AFM-based force spectroscopy
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in discriminating specific interactions, in this work between biotin and streptavidin.
Despite extensive attention this receptor-ligand pair has attracted over the years, the
existent data provide a broad range of forces and are not always complete in terms
of presented measurement parameters. Therefore, I incorporated a dsDNA tether
providing a clear B-S transition fingerprint to easily select only the single-molecule
events.
Next, using a similar experimental design, I tackled the interaction of methyl-DNA-
dependent protein MeCP2 with specific and unspecific targets. The protein is be-
lieved to loop DNA upon binding to it but little is known about the nature of this
phenomenon. Single-molecule assays were meant to address the putative role of
MeCP2 in DNA cross-linking. I employed two different single-molecule techniques
(AFM and MT) to achieve the required single-molecule resolution and analyze the
putative effect of DNA loop formation. I also designed several DNA substrates to
provide various sequence contexts optimal for the looping to occur.
Furthermore, inspired by the popularity of the GFP tag in protein research, I focused
on the GFP-Nb pair, starting with the complex’s rupture force determination. I
tackled this aspect both in terms of absolute force values (provided by AFM force
spectroscopy) as well as relative ones (using Molecular Force Assay), at which on
the one hand the technique was adapted to and tested for screening protein-protein
interactions and on the other hand - the GFP-Nb system was considered a potent
reference for measuring those.

Chapter 2
Materials and Methods
2.1 Reagents
All common chemicals were purchased from Sigma (Deisenhofen, Germany) or Roth
(Karlsruhe, Germany), unless otherwise stated. Restriction endonucleases and methyl-
transferases, Phusion Polymerase and Phusion High-Fidelity PCR Master Mix were
purchased from New England Biolabs (NEB; Ipswich, Massachusetts). Kits for DNA
cleanup (gel extraction, PCR product purification, plasmid DNA isolation) were pur-
chased from Qiagen (Qiagen AB, Sollentuna, Sweden). Consumables are listed in
Table 2.1.
Consumables Supplier
glass slide A+ (aminosilane coat-
ing)
Nexterion
glass slide E (epoxysilane coat-
ing)
Nexterion
cantilevers MLCT Bruker
cantilevers BioLever mini Olympus
Malhex-NH-PEG-O-C3H6-
CONHS
Rapp Polymere
Table 2.1: Consumables
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2.2 DNA, oligonucleotides and primers
Gene/sequence forward DNA 5’-3’ reverse DNA 5’-3’ elongationtime Ta
Nb C anchor
GTCACCGTCTCC
TCACACCACCAT
CACCATCACTGC
TAATAGTCTAG
AATTCTAGACTA
TTAGCAGTGATG
GTGATGGTGGTG
TGAGGAGACG
- 70 °C
eGFP N anchor
CATGGCATGCAG
CAAGGGCGAGGA
GCTGTTCACCG
GTGAACAGCTCC
TCGCCCTTGCTG
CATGC
- 70 °C
eGFP C anchor
GTCACCACCATC
ACCATCACTGCT
AGTAAG
AATTCTTACTAG
CAGTGATGGTGA
TGGTG
- 60 °C
T4 1.1 kb fragment
biotin-TGGAGAAG
GAGAATGAAGAA
TAATA
HS-CGGTGCTAAA
TTTATTATGACT
TCA
30 s 58 °C
mtweez loop300
CAGCTAGCTCGA
GTGGAGAAGGAG
AATGAAGAATAA
TA
GTCAGGTACCGT
GAAGTAAGTAAT
AAATGGATTGA
30 s 61 °C
GA eGFP N+C
anchor eGFP
gatcgggccgtgggtATG
GTGAGCAAGGGC
GA
tttaatttcatggtgaccA
CCCTTGTACAGC
TCGTC
30 s 61.7 °C
GA eGFP N+C
anchor hAGT
GGTCACCATGAA
ATTAAACTGGTG
ACCCACGGCCCG
ATCCT 3.5 min 67.9 °C
GA loop600_v TACAGAATCCCTAAACGC
ACCTGTCAAAGC
AGGCA 3 min 59.1 °C
GA loop600_i
gcctgctttgacaggtGG
GACCTGCGCTCT
GTC
cgtttagggattctgtaGT
ATGTTTGGCATT
AGTTCAATC
30 s 62.1 °C
GA mtweez basic
XhoI-CGC
ctcgagAGCTGTTT
GTTAACTTGC
cgCTTTTAATCTG
CTGTTTGCTC 1 min 58.2 °C
GA mtweez basic
CG-C
caaacagcagattaaaagc
gCTGCAGGAGTC
AATGGGA
tggagcgcCAGTACA
CCACATCACTTT
C
2 min 61.2 °C
GA mtweez basic
C-XhoI
gtgtactggcGCTCCA
CCTTTTTCCCCA
G
gcaagttaacaaacagctct
cgagGACTGAATTC
CATACCACATTT
G
30 s 62.4 °C
MT handle EcoRI
ATGAAAATTTGG
AGCAAAGAAGAG
G
AAAAAAGAATTC
ACTTCCGGATTA
CGGCTG
15 s 58 °C
MT handle XbaI
AAAAAACTCGAG
GATGAAAAAAAA
ACTGTTTACCAC
CATTAAAGG
CAGCAGGCGTTC
AATATTGCG 15 s 58 °C
Table 2.2: Cloning oligonucleotides
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Name 5’-3’ sequence
Nb_seq ATACCTATTGCCTACGG
pBADrev GTCGACGGCGCTATTCAG
pBADfor CACTTTGCTATGCCATAGC
eGFPup GGACACGCTGAACTTGTG
eGFPdown CCAGTCCGCCCTGAGC
tit_rev_seq CCATTGAATGCTTAGTGCC
Table 2.3: Non-standard sequencing primers
2.3 Molecular biological methods
Unless otherwise indicated, the oligos were purchased from Eurofins MWG (Ebers-
berg, Germany).
2.3.1 PCR
A typical 20 µl PCR reaction mix consisted of 10 µl HF Phusion Master Mix,
7 µl H2O, 1 µl DNA template (of 200 pg/µl to 100 ng/µl) and 1 µl each 10 µM
forward and reverse primer. PCRs using Phusion polymerase (not in a Master Mix)
were usually performed in a total volume of 50 µl. 5 µl 5x Phusion GC buffer,
1 µl polymerase, 1 µl dNTPs (PeqLab, Erlangen, Germany) 10 mM each, 1 µl
DNA template and 0.5 µl each of forward and reverse primers were added to 36
µl H2O.
Cycling conditions were adjusted for each reaction according to the manufacturer’s
instructions.
2.3.2 Cloning
Cloning of N+C-anchored eGFP, 600-bp-loop and 600-bp-loop-basic constructs was
performed using Gibson Assembly (GA) method.The other constructs were obtained
through restriction cloning. In both cases chemically competent E.coli (DH5α unless
otherwise specified) were used for subsequent transformation. Primer sequences along
with annealing temperatures and elongation times are listed in Table 2.2. Positive
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clones were confirmed by sequencing. Table 2.3 contains the list of custom-designed
sequencing primers.
Gibson Assembly cloning
Gibson Assembly cloning was performed using GA kit (NEB) and NEB online tool
for primer design, according to the manufacturer’s instructions. Following PCR,
each reaction mix was diluted 1:20 with H2O and added to 10 µl of 2x GA mix in
proportions determined based on the fragments’ length ratio.
Cloning of N+C-anchored eGFP
The eGFP insert was PCR amplified using pRSET5D_eGHis as a template and
pBAD_hAGT-TitGFP-hAGT-Strep was used as a template for backbone PCR. Both
fragments were combined using Gibson Assembly assay.
Cloning of single-anchored eGFP
N-terminal cystein was introduced to pRSET5D_eGHis by replacing an NcoI/BseRI
cut fragment by a synthetic insert with complementary overhangs. Similarly, the C-
terminal modification was achieved and the extra cystein was placed right after the
HisTag.
Cloning of Nanobodies
Terminal cystein was introduced by replacing EcoRI/BstEII cut C-terminal frag-
ment of cAbGFP4 in pHen6 by a synthetic insert with complementary overhangs,
introducing the cystein right after the HisTag, and an additional XbaI restriction
site enabling easy identification of positive clones.
Cloning of DNA constructs for magnetic tweezers
All constructs for the use with magnetic tweezers were based on the pCpGfree-lacZ
plasmid (InVivogen, San Diego, California). Chemically competent E.coli GT115
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(InVivogen) cells allowing for Zeocin (InVivogen) selection were used for transforma-
tion.
300-bp-loop construct was obtained by PCR amplifying 1.1-kb fragment with primers
introducing NheI and XhoI (forward) and Acc65I (reverse) restriction sites. Both
pCpGfree vector and PCR product were digested with NheI and Acc65I and ligated
with each other. The resulting construct features two EcoRI and one XhoI sites,
and upon linearization with those enzymes, a 5 kb fragment with 300 bp loop was
isolated.
600-bp-loop construct was generated through site directed mutagenesis of the 300-
bp-loop one (by GA cloning), introducing two M.HhaI sites 624 bp apart.
600-bp-loop-basic was prepared via assembly (GA) of three fragments, all PCR-
produced using pCpGfree-lacZ plasmid as a template. The resulting construct con-
tains single EcoRI and XhoI sites in close proximity to each other to simplify tether
preparation procedure.
To enable proper attachment of the DNA to the bead and the lower surface of the
flowcell, DNA handles were used, carrying several biotin or digoxigenin labels. The
labels were incorporated during a PCR reaction as described in [Dekker et al., 2004],
in which regular PCR mix was supplemented with biotin- (at a final concentration
of 375 µM) or digoxigenin-labeled dUTP (at a final concentration of 30 µM) (Jena
Bioscience, Jena, Germany). In both reactions, a fragment of BcnI sequence was
used as template. The 314 bp-long biotin handle was then digested with EcoRI and
the 400 bp-long digoxigenin handle with XhoI.
Actual tethers for the use with magnetic tweezers were prepared by ligating the
EcoRI/XhoI-linearised fragments with the two pre-digested handles.
2.3.3 Preparation of DNA for AFM measurements
1.1-kb-long T4 DNA fragment was PCR amplified using primers carrying terminal
functional groups: thiol for covalent attachment to gold or maleimide, and biotin for
attachment to streptavidin.
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2.3.4 DNA methylation
Two-site methylation of DNA with defined loop length was achieved enzymetically
using M.HhaI methyltransferase (NEB) according to the manufacturer’s instructions.
Methylated DNA was then test digested with HhaI restriction endonuclease cutting
unmethylated sites, ensuring that only completely methylated DNA was probed in
the experiments.
Full methylation of AFM constructs was achieved through PCR substituting dCTP
of the dNTPs mix with 5-methyl-dCTP (Jena Bioscience). This way all cytosine
residues of the PCR product were methylated.
2.4 Biochemical methods
2.4.1 Protein expression and purification
DNA constructs not mentioned in the Cloning section (2.3.2) were already available
in the library of either Gaub lab or Leonhardt lab.
In general, 1-5 l LB medium was inoculated with an overnight culture, grown to
OD600 in the range of 0.6-0.8, at which point they were induced with 0.25-0.5 mM β-
D-1-thiogalactopyranoside (AppliChem, Darmstadt, Germany) and overexpression
was carried out overnight at 20 °C (Nb) or 28 °C (GFP). The cultures were then
harvested by centrifugation at 5000 g for 10 min. The pellet was frozen at -80 °C for
at least 15 min, then thawed and resuspended in 10 ml of binding buffer (1x PBS,
pH 8.0, 0.5 M NaCl, 20 mM imidazole, 1 mM PMSF, 10 g/l lysozyme; see below
for ybbR-tagged protein). After incubation for 1 h at 4 °C, it was sonicated (6x 10
second pulse) on ice. Following centrifugation at 20000 g for 20 min, soluble fraction
was applied to a pre-equilibrated 1 ml HiTrap column (GE Healthcare, Freiburg,
Germany) and purified. Bound proteins were eluted by a linear gradient of imidazole
(20-500 mM).
Purified protein was dialyzed (overnight at 4 °C) into storage buffer (1x PBS unless
otherwise stated) and stored at 4 °C for up to 4 weeks or flash frozen and stored at
-80 °C until further use.
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Nanobodies
Nanobodies were expressed in E.coli JM109 strain suited for periplasmic expression
due to internal disulphide. Both Nanobody constructs harbor a pelB leader sequence
for periplasmic export and a C-terminal HisTag for purification. Modified Enhancer
was expressed from pHEN6-cAbGFP4FTAThis6 vector, encoding GFP-binder pre-
ceded by TAT peptide (GRKKRRQRRRPQ).
GFP
His-tagged GFP (both single-anchored eGFPs and ybbR-tagged wtGFP) were ex-
pressed in E.coli BL21 (DE3).
ybbR-tagged GFP [Pippig et al., 2014] was purified using Tris buffer system (lysis
in 50 mM Tris pH 7.5, 100 mM NaCl, 5 % glycerin, 15 mM imidazole and 10 mM
β-mercaptoethanol) and dialyzed into storage buffer (30 mM Tris pH 7.5, 100 mM
NaCl, 5 % glycerin, 2 mM DTT), then stored at -80 °C.
pGEX-2T-GFP-hAGT vector was used for expression of wtGFP with a C-terminal
hAGT anchor. The expressed GFP was fused to a GST tag used for purification. The
protein was purified in Tris/NaCl pH 8 using GST affinity column (GE Healthcare,
Freiburg, Germany) according to the manufacturer’s instructions. The GST tag was
cleaved off during purification using thrombin. The protein was stored in 1x PBS at
4 °C.
Both wtGFP and eGFP with N- and C-terminal handles were expressed in E.coli
BL21 (DE3) from pBAD-hAGT-TitGFP-hAGT-Strep vector, N-anchored wtGFP
from pBAD-hAGT-TitGFP-Strep. In each case the resulting GFP was flanked by
two stretches of four Ig domains each and featured an hAGT domain on respective
termini, as well as a C-terminal StrepTag II. The cultures were induced with arabi-
nose at a final concentration of 0.2 %, the protein was expressed overnight at 30 °C
and then purified using StrepTrap HP (GE Healthcare, Freiburg, Germany), eluted
in Tris/NaCl pH 8 and stored in 100 mM Tris 150 mM NaCl, 2 mM DTT, 5 %
glycerin, 10 µM ZnCl2 pH 7.8 at -80 °C.
GFPs for MFB [Aschenbrenner et al., 2014] were expressed from pET28a vectors
(EMD Group, Merck KGaA, Darmstadt, Germany) in E.coli BL21 DE3 CodonPlus
cells (Agilent Technologies, Inc., Santa Clara, CA, USA). All three constructs (wt-
GFP, eGFP and sfGFP) feature an N-terminal HisTag for purification followed by
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the ybbR-tag (DSLEFIASKLA). After purification with HisTrap HP columns (GE
Healthcare, Freiburg, Germany), the protein was stored in 30 mM Tris pH 7.5, 100
mM NaCl, 5 % Glycerin, 2 mM DTT at -80 °C.
MeCP2
GFP-tagged MeCP2 was provided by the Cardoso lab. The protein was expressed in
Sf9 cells and purified using the GFP-Trap (Chromotek, Martinsried, Germany). It
was eluted from the beads with 4 M MgCl2. Next, buffer exchange against 1x PBS
was performed using a 30 kDa Amicon filter (Merck Chemicals GmbH, Darmstadt,
Germany). The protein was then stored in single-use aliquots at -80 °C.
2.4.2 Electrophoretic Mobility Shift Assay
Depending on the size of the analyzed molecules, Electrophoretic Mobility Shift Assay
(EMSA) was performed either using polyacrylamide or agarose gels. Non-reducing-
PAGE was performed to analyse covalent oligonucleotide-protein complexes and
1 % agarose gel to screen DNA-binding capacity of MeCP2.
2.5 Surface and cantilever chemistry
In house modified surfaces were prepared using 1 mm-thick glass slides. These were
first sonicated in 50 % (v/v) 2-propanol in ddH2O for 15 min and oxidized in a
solution of 50 % (v/v) hydrogen peroxide (30 %) and sulfuric acid for 30 min Fol-
lowing washing in ddH2O and drying under nitrogen flow, desired modification was
performed.
Evaporation of gold surfaces
A 250 Å layer of gold was deposited on clean glass slides precoated with chromium-
nickel (25 Å) to promote hydrophobic gold adhesion to otherwise hydrophilic glass
surface.
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Preparation of amino- and epoxy-functionalized slides
Glass slides were silanized by soaking in a solution of 90 % (v/v) ethanol, 8 % ddH2O
and 2 % epoxysilane or its 3-aminopropyldimethyl derivative (ABCR, Germany)
for 1 h. Subsequently they were washed twice in isopropanol and ddH2O and dried at
80 °C for 40 min. At this stage the glass slides were stored under argon atmosphere
for up to two months and further functionalization steps were performed directly
before the measurement.
Alternatively, commercial amino- or epoxy-functionalized slides (Nexterion) were
used.
Slide and cantilever functionalization for AFM
Maleimide-thiol chemistry: Maleimide-thiol chemistry was performed using amino-
slides. The amino groups were deprotonated by incubation in sodium-borate buffer at
pH 8.5 for 0.5 h at room temperature. Next, heterobifunctional PEG crosslinker with
NHS and maleimide groups (MW 5000 Da, Rapp Polymere, Tübingen, Germany)
was applied at 30 mM in sodium borate buffer at pH 8.5 for 1 h at room temperature.
After washing in ddH2O, the slides were dried and protein with a free, reduced thiol
group was applied.
ybbR chemistry: anchoring of ybbR-tagged proteins was performed using amino-
slides. Following deprotonation and pegylation as described above, the slides were
washed with H2O and incubated with 50 µl. After 1 h, 1 µl TCEP was applied for
5-10 min to destroy unreacted maleimide groups. The slides were then washed with
H2O and protein mix (40 µl of 2.5 µM ybbR-GFP in 1x PBS, 1 µl SFP and 4.6 µl
SFP buffer) was applied. After 2 h of incubation at room temperature, the slides
were washed in 1x PBS.
hAGT chemistry: hAGT anchoring was performed on epoxy-functionalized slides.
Heterobifunctional PEG crosslinker with -NH2 and -COOH functional groups (MW
5000 Da, Rapp Polymere, T§übingen, Germany) was applied at 50 mM in sodium-
borate buffer at pH 8.5 and incubated overnight at room temperature. After rinsing
with water, -COOH groups were activated with 100 mM EDC/NHS solution (in
H2O). Following 20 min incubation, the slides were rinsed with ddH2O and 150 ul
of 4 mM NH2-PEG-BG (stored as 40 mM stock in DMF) in 100 mM EDC/NHS in
borate buffer was applied for 3 h at room temperature. After rinsing with water,
hAGT-tagged GFP was applied and incubated for 45 min.
34 2. Materials and Methods
Cantilever functionalization: Cantilevers were cleansed (activated) by exposition to
UV radiation under ozone atmosphere for 10 min. Then they were silanized by
immersing for 1 min in 3-aminopropyldimethylepoxysilane diluted 1:1 in ethanol
with addition of 1 µl of H2O. Following washing in toluol and water, and drying,
they were incubated at 80 °C for 30 min. Subsequently, either 1 mM streptavidin in
1x PBS was applied directly or pegylation followed by Nb application was performed
as described for slide functionalization.
Preparation of flow cell for MT
Schematic of a flowcell for magnetic tweezers is presented in Fig. 2.1. Two rectangular
coverslips are separated by a thin layer of parafilm, which also keeps them together
and seals the edges of the cell. The top coverslip features two apertures - inlet and
outlet. Inlet chamber is made of the wide part of pipet tip attached to the inlet and
acts as a liquid reservoir. Tubing attached to the outlet is connected to a syringe
operated by an automated motor.
Figure 2.1: Schematic of a flowcell for magnetic tweezers experiment. Parafilm be-
tween the upper and the lower surface of the cell (rectangular coverslips) acts both
as an adhesive and a spacer. Flow of liquid from the reservoir (yellow) towards the
outlet is regulated by an engine-operated syringe.
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2.6 Biophysical methods
Atomic Force Microscopy
Single-molecule force spectroscopy experiments were performed using commercial
MFP-3D AFM (Asylum Research) and a custom built instrument with an MFP-3D
controller. Two types of cantilevers were used: MLCT (cantilever C) by Bruker and
Biolever mini (BL-AC40TS-C2) by Olympus. Cantilever and slide were modified each
with one of the interaction partners to be investigated. For each measurement can-
tilever spring constants were calibrated in solution using the equipartition theorem
[Butt and Jaschke, 1995]. The bond strengths were tested in series of measurements
at various pulling speeds ranging from 300 nm/s to 10000 nm/s. A single measure-
ment cycle consisted of approach, short (< 1 s) dwell at the surface and retraction
of the cantilever with constant velocity. An exemplary force-distance curve resulting
from a single probing cycle is shown in Fig. 2.2.
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Figure 2.2: A typical force-distance curve resulting from single-molecule probing with
AFM. Blue trace - experimental data, red curve - fitted WLC model.
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Molecular Force Assay
MFA measurements were performed using a custom-built set-up based on an in-
verted epifluorescence microscope with piezo-actuated head moving the PDMS stamp
against the probed surface. Each Molecular Force Balance (MFB) consisted of a Nb-
GFP pair and a DNA oligonucleotide duplex (oligos for MFA were purchased at
Biomers.net, Ulm, Germany). To ensure attachment of complete duplexes, CoA-
labeled strand was premixed with a 2-fold excess of a biotinylated strand. The Nbs
were immobilized on the glass surface via a polymer linker and then GFP-DNA com-
plexes were bound to them. A complementary DNA strand was attached to the
PDMS stamp. The stamp format (4x4 patches) allows for analysis of 16 different
MFBs in a single experiment. As in the standard MFA, DNA oligonucleotides car-
ried Cy3 and Cy5 labels allowing fluorescence readout. The fluorescence of GFP
was not essential for the evaluation of the outcome but provided a convenient online
control of sample quality. Indeed, GFP fluorescence signal colocalized with that of
Cy3 and Cy5, confirming the specific interaction and correct assembly of protein
force balances.
In each experiment fluorescent scans in both red and FRET channel were performed
prior to, as well as right after stamping. In between, the stamp was moved towards
the surface and kept there for 10 min to allow for correct MFBs assembly by biotin-
streptavidin coupling. A piezo actuator controlled stamp retraction at a constant
speed of 1 µm/s (corresponding to a loading rate in a range of 105 pN/s) resulted
in force build-up along each MFB and subsequent failure, statistically of the weaker
of the two bonds. The outcome of the experiment was determined based on the
ratio of the fluorophores remaining at the surface. The "red" ratio informed of
the remaining intact bonds as compared to the initial number of bonds while the
FRET ratio referred to the complexes which were not probed and thus allowed the
correction for false positive signal. Since all the pictures are affected by the gaussian
shape of the illuminating beam, pixel-by-pixel analysis was applied as it has proven
to effectively cancel out the resulting inhomogeneities.
Magnetic tweezers
Magnetic tweezers experiments were performed using two different custom-built set-
ups, both based on permanent magnets. Single-bead set-up allowed for tracking of
one tether molecule along with one reference bead. On the other hand, multiple-bead
set-up offered the possibility of subsequent tracking of many beads (both tethered
2.6 Biophysical methods 37
and reference ones). The actual number of tracked tethers in one experiment was
limited by their availability in the field of view. Usually 5 to 9 tethers were analyzed,
and only the ones behaving correctly throughout the whole measurement process
were included in the final calculations.
The pattern of diffraction rings depends on the distance of the bead to the focal
plane. Before the actual measurement, a z-Look-Up-Table was created to enable
tether length determination based on the image of the bead. For this purpose, the
objective was moved stepwise in the z-direction and a picture was taken at every 100
nm step. By interpolation, the position can be estimated with about 10 nm accuracy
using this method [Gosse and Croquette, 2002].
In a typical experiment, streptavidin-coated superparamagnetic Dynabeads M-270
(φ = 2.8 µm) (Thermo Fischer Scientific, Braunschweig, Germany) were used to cre-
ate tethers and 1.0 µm polystyrene beads (Polysciences Europe GmBH, Eppelheim,
Germany) as reference beads, unspecifically stuck to the bottom of the flowcell. The
flowcell was mounted on an oil immersion objective and could be manipulated by two
motorized stages: a linear one and a rotary one allowed for the automated movement
of the magnets resulting in manipulation with the beads. The objective mounted on
a piezo stage was moved in the z direction against the flowcell. The beads were intro-
duced to the flowcell once it was mounted on the instrument so that the tethers could
be controlled throughout the preparation phase. The measurement consisted of two
parts: first bare tethers were scanned at different forces, then protein was added and
after a short (a few min) equilibration time, the actual measurement according to
the same force pattern was performed.

Chapter 3
Results
This chapter presents the results of single-molecule screening of protein-ligand,
protein-DNA and protein-protein interactions. First, force measurements of the
streptavidin-biotin complex were performed using AFM to test single-molecule ac-
cessibility and at the same time provide quantitative data on the strength of the
complex under external load. Next, this and several other techniques were used to
tackle the challenge of single-molecule accessibility and to complement each other in
explaining biomolecular interactions.
3.1 Single-molecule force measurements of
streptavidin-biotin complex
The streptavidin-biotin complex was subjected to single-molecule force measure-
ments using Atomic Force Microscope (AFM). Experimental design assumed in-
corporation of a 1.1-kilobase-long DNA linker between the gold surface and the
biotin molecule, as presented in Fig. 3.1, providing a B-S transition fingerprint
upon stretching under load. This way force-extension curves displaying only single
interactions could be extracted for further analysis. All measurements were carried
out in 1x PBS.
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3.1.1 DNA construct preparation
1.1 kb dsDNA fragment was produced by PCR with primers introducing two terminal
modifications: a thiol group at one terminus and biotin at the other one. The thio-
lated end facilitated covalent attachment of the molecule to the gold surface.
3.1.2 Streptavidin-biotin force spectroscopy using AFM
Within a single cycle, the cantilever functionalized with covalently immobilized strep-
tavidin was brought in contact with the surface allowing surface-bound biotinylated
DNA to bind to the SA. The cantilever was then retracted causing the DNA tether to
overstretch and finally rupture. Biotin-streptavidin bond was considered the weakest
link here (apart from the long DNA duplex held together by multiple non-covalent
bonds, it was the only non-covalent one) and so statistically should break first.
Figure 3.1: Streptavidin-biotin rupture force determination - experimental design.
A 1.1-kb-long dsDNA fragment is stretched between an SA-functionalized cantilever
and surface. B-S transition of DNA observed upon external load provides a finger-
print thus allowing the selection of single-molecule events.
The analysis comprised 542 curves collected at pulling velocity of 2 µm/s, out of
which 102 were qualified based on full single B-S transition trace. Force-distance
plot representing the selected events is shown in Fig. 3.2 along with a histogram of
measured rupture forces. Fitting a Gaussian to the force distribution resulted in
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the most probable rupture force of 165.6 ± 3.1 pN. The force distribution also shows
a shoulder at larger values.
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Figure 3.2: Determination of rupture force of the streptavidin-biotin complex: force-
distance plot for the selected curves. Gaussian fit to the histogram of measured forces
provides the most probable rupture force.
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3.2 Analysis of DNA cross-linking by MeCP2
Owing to the wide attention MeCP2 has experienced in the past years, its structural
composition and biochemistry have been well described, yet the mechanism of its
binding to DNA still lacks a detailed understanding. Here, the MeCP2-DNA complex
was investigated using single-molecule techniques: Atomic Force Microscopy and
Magnetic Tweezers. In both cases the behavior of a specifically designed single DNA
molecule during stretching in absence or presence of MeCP2 is analyzed, focusing on
intramolecular versus intermolecular DNA cross-linking upon protein binding.
Loops created upon MeCP2 cross-linking of DNA have been observed by AFM imag-
ing [Ghosh et al., 2010a]. There, nodes harboring both single as well as multiple
protein moieties were identified.
3.2.1 AFM measurements
The following section describes experiments performed in part together with another
PhD student, Philip Severin.
We performed AFM measurements using a similar setup as described in section 3.1.
Initially, two types of DNA constructs were investigated: a non-methylated one -
described above - and a fully methylated one.
Preparation of fully methylated DNA
Fully methylated DNA was prepared by PCR using 5mC instead of standard cyto-
sine in the nucleotide mix. This way all 35 CpGs of the 1.1-kb-long fragment were
methylated. The same primers with terminal modifications were used as for the
non-methylated product.
MeCP2 binding to DNA - EMSA test
The ability of MeCP2 to recognise its DNA target was checked by an EMSA test.
A 2-fold dilution series of the stock protein (stock concentration 2.3 µM) was mixed
with fully methylated DNA and after 5-10 minutes of incubation subjected to elec-
trophoresis using a 1 % agarose gel, presented in Fig. 3.3. Band shifts can be
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observed for the first two dilutions of MeCP2. In all lanes a secondary band can be
seen, representing DNA dimers due to terminal thiols forming disulphide bonds.
L 1 1:2 1:4 1:8 1:16 1:32 -
1 kb
MeCP2 dil.
Figure 3.3: Electromobility Shift Assay of MeCP2-bound DNA. MeCP2 bands ap-
pear upshifted in the second and third lane. Secondary band at around 2.2 kb can
be observed in the other lanes due to DNA dimerising via thiolated ends.
Overstretching non-methylated and fully methylated DNA
First, the surface was probed with a cantilever functionalized with covalently immo-
bilized SA to ensure decent picking efficiency, that is around 10 % of curves repre-
senting a single DNA tether. It is important to mention that a full B-S transition
curve can only be recorded for a nick-free dsDNA, i.e. one featuring a continuous
sugar-phosphate backbone. As nicks occur spontaneously due to mechanical shear-
ing during preparation and handling of the DNA as well as when it is dried on the
surface, some curves display only part of the expected pattern, with the rupture
happening already in the plateau region. Yet the proportion of full B-S curves was
a deciding factor in determining whether to proceed further with the sample. Apart
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from providing sample quality information, the measurement prior to addition of
the protein constituted also a control for comparison with the effects caused by its
presence.
Effect of MeCP2 and MBD on the behavior of probed DNA
For sample quality determination, the surface was first probed a few dozen times prior
to addition of the protein and if a sufficient frequency of B-S transition fingerprint
(see Fig. 3.4) in the recorded curves was observed, the experiment proceeded to
the next step - involving protein. Typically 40 µl of freshly thawed MeCP2 was
added to the approximate volume of 1 ml buffer on the surface and mixed by gently
pipetting. Due to evaporation issues, during longer measurements supplementation
of buffer was necessary. The sample was left to equilibrate for 20 minutes before
force spectroscopy was performed. In all experiments with fully methylated DNA,
after addition of MeCP2 no more B-S transition curves were observed. Instead, a
hump-shaped peak of up to a few hundred pN appeared right at the beginning of the
force-distance curve when retracting the cantilever from the surface. To get a deeper
insight into the origin of the “hump", the automated cycling of the cantilever was
replaced by a hand-controlled procedure using the “Hamster" knob of the MFP-3D
controller. This allowed for a more gentle probing as the cantilever was retracted
once it touched the surface, without indenting it further. The resulting force-distance
profiles display a behavior not observed previously: the force first built up to over 100
pN to then drop stepwise as the cantilever was retracted further away. The pattern
of regular steps of about 28 pN each is presented in Fig. 3.5. This phenomenon
occurred a few times more in the analyzed set of a few hundred curves.
Interestingly, addition of MBD (in case of either DNA type) instead of MeCP2 did
not affect the shape of the force curves and full B-S transition patterns were recorded
also in its presence. Neither did non-methylated DNA show any change in behavior
upon addition of the full-length MeCP2.
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Figure 3.4: An exemplary force-distance curve obtained during overstretching the
DNA in absence of MeCP2 displays the well-known B-S transition pattern.
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Figure 3.5: Force-distance curve obtained for stretching DNA in presence of MeCP2
shows a pattern of regular steps of about 28 pN each.
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2-site methylated DNA
The intriguing pattern of steps inspired further AFM experiments with DNA con-
structs designed so as to facilitate formation of a loop of a strictly defined size. To
realize this, the 1.1 kb DNA fragment was in vitro methylated using M.HhaI methyl-
transferase, recognizing 5’-GCGC-3’ palindromic sequence and adding a methyl group
to the internal cytosine. The DNA fragment used harbors two recognition sites for
this enzyme, separated by 309 bp which corresponds to double the persistence length
of dsDNA and, hence, was considered optimal for efficient MeCP2-stabilized loop for-
mation. Stretching such dsDNA was expected to yield a B-S transition trace of a
molecule with contour length shorter by the loop size - up to the force high enough to
open up the loop, at which the tether should regain its initial contour length.
However, also for 2-site methylated DNA only the hump pattern was observed in
presence of the protein. Despite numerous attempts, it was not possible to achieve
single-molecule resolution with AFM. Apparently, surface density of DNA required
to ensure sufficient picking efficiency disturbed single-molecule events by causing in-
termolecular cross-links (see Fig. 3.6). Therefore we decided to proceed with an al-
ternative single-molecule technique, offering better possibilities in this respect.
Figure 3.6: Intra- vs. intermolecular cross-linking of DNA by MeCP2 cannot be
resolved using AFM due to too high surface density of molecules.
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3.2.2 Magnetic Tweezers experiments
The following section presents experiments performed together with a master stu-
dent, Philipp Walker.
After the promising initial results, we looked for complementary techniques which
could help overcome the limitations intrinsic to the AFM. Magnetic tweezers (MT)
seemed to be a perfect approach, offering control over single DNA tethers.
MT DNA constructs preparation
Several custom-designed DNA constructs were prepared, all utilizing the same princi-
ple of ligating three fragments: an insert and two "handles" responsible for anchoring
the molecule to the bead and the surface. The handles were universal for all con-
structs. Both were produced by PCR: the biotin-labeled one was 314 bp long and
the digoxigenin-labeled one 400 bp. Modified dUTP was added to the PCR mix-
ture to compete with standard thymidine during strand elongation, resulting in the
handles containing on average about 20 labels each. Prior to ligation, each handle
was digested with the respective restriction endonuclease creating single-stranded
overhangs complementary to those of the digested insert DNA. Figure 3.7 presents
a schematic sketch of produced DNA constructs.
Design of MT DNA inserts
The purpose of using magnetic tweezers was to complement the AFM findings re-
garding MeCP2-DNA binding mechanisms. Therefore, the previously used T4-1.1
kb-fragment DNA construct was adjusted to match the MT requirements. As such,
the molecule would be too short to be well resolved with the MT. Therefore, it had to
be incorporated in a longer DNA. Commercially available pCpGfree-LacZ plasmid,
carrying the CpG allele of the lacZ gene, was chosen as the framework DNA as this
way no further CpG sites were introduced, which could interfere with the expected
pattern of specific MeCP2 binding. The newly cloned plasmid contained XhoI and
two EcoRI restriction sites and linearization with these endonucleases resulted in a
5 kb fragment. All pCpGfree-lacZ constructs were transformed into E.coli GT115
cells.
Two constructs suited for MT measurements were obtained. The initial cloning of
the 1.1 kb fragment into CpG free plasmid yielded a 5 kb DNA tether with 300 bp
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loop. The loop was then extended to 600 bp in the second construct by introducing
two point mutations - one removing one of the methylation sites and the other
creating it 300 bp upstream. Doubling the distance between the methylated sites
was supposed to provide more flexibility in the loop formation and thus loosen it.
The second construct was also optimized for the process of MT DNA preparation -
the additional EcoRI restriction site was removed, which saved up an additional gel
purification step. In this case the resulting tether was 6 kb long.
In vitro DNA Methylation
Methylation of DNA designed to form a loop was achieved enzymatically. M.HhaI
methyltransferase recognizing the 5’-GCGC-3’ was used to prepare the 2-site methy-
lated DNA. For a single-molecule experiment, during which only a few molecules
are screened, highest efficiency of the reaction is crucial. The extent of in vitro
methylation was therefore verified by subsequent digestion with HhaI restriction en-
donuclease discriminating between methylated and thus protected GCGC sequences
and unmethylated ones, which were cut. Only fully methylated constructs remained
full-length and formed complete tethers in the flowcell.
The construct with fully methylated T4 1.1 kb insert for assay test was obtained
by methylating the DNA with M.SssI methyltransferase, recognising the 5’-CG-3’
dinucleotide. Here the objective was to get a few sites within a DNA molecule
methylated among the 35 available CpGs and the efficiency of the reaction was not
tested.
3.2.3 Loop detection using type II restriction endonuclease -
assay test.
In order to test the feasibility of loop detection by the assay, we employed a type
II restriction endonuclease EcoRII (Thermo Fischer Scientific, Braunschweig, Ger-
many), which binds a dsDNA molecule interacting with two or three recognition sites.
Under optimal conditions, one of the sites is cut, while the others act as allosteric
activators. Since the objective here was to observe the shortening of DNA tether
upon multiple sites binding by one enzyme moiety, the endonuclease activity was
blocked by not providing essential magnesium ions and addition of EDTA. This way,
upon binding, the enzyme should remain fixed to the DNA. All measurements were
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performed using standard reaction buffer recommended by the manufacturer but de-
void of Mg2+ and supplemented by EDTA. The measurements were conducted at
room temperature.
The procedure was similar as in the case of MeCP2 experiments. M270 beads were
used and four DNA tethers were analyzed, as shown in Fig. 3.8 a). First the tethers
were stretched in absence of EcoRII to make sure no shortening occurs. Following
addition of the enzyme, the system was screened at four different force values (2 pN,
4 pN, 10 pN and 16 pN) applied in separate force cycles. A single cycle consisted of
eight repetitions of the following protocol: equilibration at low force (0.16 pN) for 90
seconds followed by stretching the tethers at a given force for 300 seconds and then
rupturing all the remaining loops at high force (25 pN) for 15 seconds. The force of
25 pN proved to be high enough to restore the initial contour length of the tethers.
Eight cycles of blank measurement yielded a single tether length change, whereas for
measurements involving the enzyme 63 length changes were recorded for the 2 pN
force trace and 30 for the 4 pN one. At 10 pN only one length change was observed
and no changes occurred at 16 pN.
Finally, after buffer exchange against EcoRII-optimal one, all tethers were lost during
a 300 s incubation at 0.16 pN, indicating successful cleavage of the DNA (Fig. 3.8
b) - before and c) - after cleavage).
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1136 bp T4 DNA fragment for AFM
C* (GCGC): 797 & 1106; (CCGG): 564, 818 & 1077
-SH
300 bp loop DNA for magnetic tweezers
5 kb long, C* (GCGC): 3902 & 4211
EcoRI XhoI
600 bp loop DNA for magnetic tweezers
5 kb long, C* (GCGC): 3587 & 4211
EcoRI XhoI
600 bp loop DNA for magnetic tweezers
6 kb long, C* (GCGC): 3554 & 4145
EcoRI XhoI
1136 bp T4 DNA fragment for AFM
fully methylated
-SH
1 kb insert DNA for magnetic tweezers
5 kb long, incl. 1 kb methylated fragment
EcoRI XhoI
Figure 3.7: DNA constructs used to investigate MeCP2-induced DNA cross-linking.
Stars indicate methylated CpG sites recognized by MeCP2.
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6.9 EcoRII DNA Cleavage 83
measured DNA
molecules
DNA molecules
not measured
a)
b)
c)
Figure 6.36: EcoRII-DNA cleavage. Field of view of the EcoRII measurement. Green beads: measured
DNA tether in chapter 6.8. Yellow beads: not measured beads due to two DNA tethers
at one bead ar di↵raction ring pattern partly out of field of view. a) DNA-molecules
attached to M270 beads and stretched at 10 pN in bu↵er containing no Mg2+. b) Picture
taken immediately after the bu↵er exchange (“Bu↵er O”) at 10 pN. c) After 5 minutes
incubation at 0.16 pN all tracked beads are gone.
Figure 3.8: Loop d tection assay test - field of view of the magnetic tweezers. Circular
markers show locations of beads representing single, measurable tethers (in green)
as well as a double tether and a tether appearing too close to the edge of the field
of view, both of which could not be measured (yellow). The same field of view is
pictured at 10 pN stretching force without Mg2+ (a), with Mg2+ - right after buffer
exchange (b), and after 300 seconds incubation (c) - when all tracked beads are gone.
(Fig.: P. Walker)
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3.2.4 DNA looping upon MeCP2 binding
300 bp loop
The ability of MeCP2 to stabilize DNA loops was first investigated using the
300 bp loop DNA construct. The defined positions of methylated sites recognized
by the protein determined the predicted size of the loop. We expected to observe
MeCP2-stabilized loop formation manifested by the shortening of the tether contour
length by the length of the loop. Conversely, opening up an existing loop would
result in tether elongation. The change of contour length is force-dependent and for
the 300 bp loop size, based on the WLC model equals respectively 89 nm for 1 pN,
94 nm for 2 pN, 98 nm for 5 pN and 101 nm for 9 pN.
Nine tethers from nine independent experiments using the single-bead setup were
measured, first without and then with MeCP2. Blank measurements (in absence
of the protein) constituted a reference and were performed according to the same
protocol as the ones with MeCP2. All these experiments were performed in 1x PBS
buffer to provide comparable conditions to those from the AFM measurements. The
force was applied in several series, starting at 0.1 pN, to 1 pN, to 2 pN, to 5 pN and
finally 9 pN, after which the cycle was repeated. Fig. 3.9 presents an exemplary
fraction of the force protocol applied for loop detection. A total of several hundred
cycles were applied in each experiment. During the low force step (0.1 pN) the DNA
was rather relaxed, yet the tethered bead was prevented from getting irreversibly
stuck to the surface. For the same reason, during the addition of MeCP2 the tethers
were stretched at 10 pN to compensate for the shear flow of the liquid inside the
flow cell. The algorithm of loop searching assumed comparison of the z positions of
a given bead at a given force in two consecutive force cycles. This way the influence
of long term drift was minimized. Negative values represent tether shortening and
positive ones - elongation. Fig. 3.10 illustrates tether length changes between each
two consecutive force plateaus. For the evaluation, for each force value, data from
all nine experiments were pooled together and plotted as a histogram of z position
changes. Ideally, there should be almost no changes for the blank measurements and
in the presence of MeCP2 (loop forming) two peaks: one at the negative and one at
the positive value of the expected contour length change were expected.
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6.1 MeCP2-DNA Loop Formation 35
Before the MeCP2 is added, the measurement protocol was repeated several times to obtain
reference values in a blank measurement. While flushing the protein inside the flowcell, the
DNA tethers were stretched with 10 pN to avoid loop formation during flushing as well as
to prevent unspecific binding of the beads to the surface. The tether length before and after
flushing was compared to check for unexpected changes in length.
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Figure 6.1: Force cycle to detect MeCP2-DNA loops. a) DNA extension. b) Motor position. The
applied forces and resting times are written in the plot. Idle time at 0.1 pN was changed
during the measurements from 30 seconds to 20 minutes. Increasing the force to 40 pN is
intended to rupture possible loops.
Figure 3.9: Loop detection. Top: tether length changes during force protocol appli-
cation. Stretching the teth r results in a remarkable decrease of the noise. Bottom:
force protocol resulting in the force trace presented above. Force values are deter-
mined by the distance between the flow cell and the magnets. (Fig.: P. Walker)
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Figure 3.10: 300 bp loop DNA: contour length analysis of 9 tethers at various pulling
forces, over all force cycles; top: no MeCP2, inset shows zoomed-in peak, bottom:
with MeCP2. Histograms show tether length changes between two consecutive force
plateaus. Top: blank measurement, bottom: measurement with MeCP2.
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Figure 3.11: 300 bp loop DNA: contour length analysis of 9 tethers at various pulling
forces, over all force cycles. Histograms of tether length changes for each plateau as
compared to the first plateau at a given force regime. Top: blank measurement,
bottom: measurement with MeCP2.
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Figure 3.12: 300 bp loop DNA: contour length analysis of 9 tethers at various pulling
forces, over all force cycles; top: blank measurement, bottom: with MeCP2. Tether
length stability within each plateau for each force regime. Histograms show differ-
ences between the mean of the first 60 points and the mean of the last 60 points
within each plateau.
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For all blank measurements, the great majority of contour length changes fell into
the ± 20 nm regime. There was a negligible number of changes recorded around the
values expected for the specific loop. Fig. 3.11 presents the relation of each plateau
at a given force to the first plateau at that force in the measurement. The shift of
the centre of the distribution reflects the observed longterm drift of the setup. On
the other hand, stability of the measurements within a single plateau is confirmed
by the last histogram in the series (Fig. 3.12), in which the difference between the
mean of the last and the first 60 points of each plateau is plotted.
Measurements in presence of MeCP2 did not show the expected pattern of the his-
tograms. Sparse events at the expected distance from zero did not constitute evidence
for loop detection in either of the applied force regimes. The same holds true for
the comparison of the z position of all plateaus to the first plateau in the measure-
ment. Similarly as in blank measurements, due to the system drift the centre of the
contour length change distribution was shifted in all histograms (Fig. 3.11), while
within plateaus no significant change could be observed (Fig. 3.12).
600 bp loop
To check if a more flexible loop would be more likely to form or more easily resolved
by the assay, measurements with DNA carrying two methylated sites separated by
600 bp were performed at two different force steps. Here buffer conditions described
in [Ghosh et al., 2010a] were used, i.e. Tris at pH 7.5, 200 mM NaCl, 0.5 mM EDTA.
The expected contour length changes upon loop formation were again calculated
based on the WLC model and yielded: 180 nm for 2 pN and 193 nm for 9 pN.
The experiment was performed using the Multibead setup with M270 beads and
three tethers from a single measurement qualified for the analysis. For the contour
length changes a similar protocol as above was applied, only two force steps (2 pN
and 9 pN) were implemented. The resulting histograms of observed contour length
changes are presented in Fig. 3.13. In both cases almost no events could be found in
the range of interest. The histograms for measurements at 9 pN look a lot "cleaner"
than those for 2 pN, in which a lot of drift could be observed resulting in a shoulder
of the central peak towards positive values (reaching almost 200 pN). Interestingly,
that shoulder is more pronounced in the blank measurement than in any of the
measurements with MeCP2 present. In either case it is not accompanied by a peak
on the negative half-axis. All histograms for the 9 pN step are centered close to zero
and events of lengthening or shortening are sparse, if any.
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Figure 3.13: 600 bp loop DNA contour length analysis at 2 pN (a) and 9 pN (b)
with MeCP2 at various stock dilutions.
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600 bp loop DNA in high salt buffer
Next, to increase the specificity of MeCP2 recognition of its target sequence, NaCl
concentration in the assay buffer (1x PBS) was increased to 300 mM. The persistence
length of dsDNA remains comparable to that in pure 1x PBS so expected values of
tether shortening did not change.
This time the blank measurement comprised 3 tethers from three separate flow cells
and three additional tethers were analyzed in presence of MeCP2 resulting in six
tethers contributing to the histograms of MeCP2 measurements. Fig. 3.14 presents
tether length changes between two consecutive force plateaus, Fig. 3.15 - tether
length stability over the whole duration of the measurement and Fig. 3.16 shows
tether length stability within plateau. No contour length changes in the expected
range can be found either in the blank measurements or in the measurements in
presence of the protein indicating that no MeCP2-stabilized loops could be observed.
Unexpected peaks appear in blank measurement histograms of long range drift: at
around 100 nm in the 1 pN trace and around 80 nm in the 2 pN trace, while the other
two traces look normal (Fig. 3.15 (a)). The satellite peaks result most probably from
a dust particle disturbing part of the readouts.
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Figure 3.14: 600 bp loop DNA contour length analysis of 6 tethers in high salt
buffer at various pulling forces, over all force cycles. Histograms of the tether length
changes between two consecutive force plateaus. Top: blank measurement, bottom:
with MeCP2.
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Figure 3.15: 600 bp loop DNA contour length analysis of 6 tethers in high salt buffer,
at various pulling forces, over all force cycles. Histograms of tether length changes
for each plateau as compared to the first plateau at a given force regime. Top: blank
measurement, bottom: with MeCP2.
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Figure 3.16: 600 bp loop DNA contour length analysis of 6 tethers in high salt buffer
at various pulling forces, over all force cycles; top: blank measurement, bottom: with
MeCP2. Graph illustrates tether length stability within each plateau for each force
regime. Histograms show differences between the mean of the first 60 points and the
mean of the last 60 points within each plateau..
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Fully methylated 1.1 kb fragment
Here the DNA construct with 35 methylated MeCP2 recognition sites spread across
a 1.1 kb stretch was used, providing methylated CpG sites in diverse nucleotide
contexts. The resultant protein-stabilized loops of various size were expected and a
shortening corresponding to up to around 1 kb loop should be observed. The exact
size of the formed loop (or loops) was not the central point in this test, rather the sole
possibility to observe shortened DNA tether upon MeCP2 interaction with it. Again,
the blank measurements were followed by ones in the presence of MeCP2. In either
case, almost no events could be observed. Loop search by comparing two consecutive
plateaus resulted in a single sharp peak at 0 nm (3.17). Few deviations from 0 can be
observed in the histogram of tether length changes between two consecutive plateaus
(3.18) or in the histogram of tether length changes within a one plateau (3.19). The
single examples of tether shortening recorded in the ± 200 nm range did not provide
enough basis for reasonable statistics.
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Figure 3.17: 1 kb methylated DNA contour length analysis of 6 tethers at various
pulling forces, over all force cycles. Histograms of the tether length changes between
two consecutive force plateaus. Top: blank measurement, bottom: with MeCP2.
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Figure 3.18: 1 kb methylated DNA contour length analysis of 6 tethers at various
pulling forces, over all force cycles. Histograms of tether length changes for each
plateau as compared to the first plateau at a given force regime. Top: blank mea-
surement, bottom: measurement with MeCP2.
66 3. Results
50
40
30
20
10
0
Co
un
ts
-400 -200 0 200 400
length change [nm]
1 pN
2 pN
5 pN
9 pN
200
150
100
50
0
Co
un
ts
-200 -100 0 100 200
length change [nm]
1 pN
2 pN
5 pN
9 pN
with MeCP2
no MeCP2
a
b
Figure 3.19: 1 kb methylated DNA contour length analysis of 6 tethers at various
pulling forces, over all force cycles; top: blank measurement, bottom: with MeCP2.
Graph illustrates tether length stability within each plateau for each force regime.
Histograms show differences between the mean of the first 60 points and the mean
of the last 60 points within each plateau.
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3.3 GFP-Nanobody binding strength determination
Given the versatility of the Nb-GFP complex and the multitude of its practical
applications, it is interesting to describe these binding partners both in the absolute
values as well as in relation to other known biomolecular complexes. The former point
was accomplished by incorporating the protein pair in the Molecular Force Balance.
The latter - by performing Single-Molecule Force Spectroscopy using AFM. Next,
the complex was tested towards its usefulness in Single-Molecule Cut&Paste.
3.3.1 Strength of Nb-GFP complex as compared to other
biomolecular interactions
Cloning, expression and purification of Nanobody for subsequent covalent
immobilization
For the purpose of this work, the Nanobody with a C-terminal cystein for covalent
immobilization was cloned and expressed as described in chapter 2, section 2.3.2.
Expression in a 10 l culture yielded about 6 mg pure protein. Stepwise results of a
two-step purification procedure are presented in figures 3.20 and 3.21.
FTP L
puried fractions
A11 A10 A9 A6 A5 A3
10 kDa
15 kDa
27 kDa
70 kDa
M
Figure 3.20: Nb-Cys sample purified over HisTrap column analyzed on 15 % SDS
PAGE. P - pellet, L - lysate, FT - flow through, M - protein molecular weight marker.
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Figure 3.21: Nb-Cys sample after the second step of purification - over Superdex 75
column analyzed on 15 % SDS PAGE. M - protein molecular weight marker.
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Preparation of covalent protein-DNA complex
To correctly place the Nb-GFP interaction in a wider context of biomolecular inter-
actions, Molecular Force Balance - so far limited to DNA samples - was adapted to
the use of proteins. The first challenge was to efficiently attach the DNA oligonu-
cleotide to the protein of interest. Several strategies were tested, some leading to
a fraction of reagents correctly coupled, yet leaving the majority of both DNA and
protein unreacted. Exemplary results of an attempt to covalently couple maleimide-
modified DNA strand to GFP exposing reduced cysteine are shown in Fig. 3.22. Two
reducing agents TCEP (at a final concentration of about 50 mM) and DTT (at a
final concentration of 10 mM) were used to maintain thiols on the GFP in a reduced
state. After incubation, samples were separated by non-reducing electrophoresis and
then scanned against GFP and Cy3 attached to the DNA. The picture presents an
overlay of both channels. The fact that GFP fluorescence depends on intact ter-
tiary structure of the protein indicates that the use of reducing agents at the applied
concentrations is not harmful to its integrity. Overlapping bands (outlined in pink)
represent protein-DNA complexes. However, they constitute only a minor fraction of
the total amount of material loaded. The DNA control lane displays also a band near
the level of the band representing the complex. A respective band can also be seen
in the third lane (GFP-DNA-TCEP), clearly distinctive from the one representing
the complex.
In another approach, maleimide-functionalized streptavidin was reacted to eGFP
carrying a terminal thiol group and hybrids formed in this way were mixed with
biotinylated ssDNA. Streptavidin was used in a 10-fold dilution series in 1x PBS,
starting at a concentration of 1 mg/ml. In this assay 10 µl of SA solution was mixed
with 3 µl of TCEP-reduced eGFP-SH and following one-hour incubation, biotinylated
DNA was added (1 µl of 0.033 µM DNA in 1x PBS per sample). Cy3 labels on the
DNA allowed for direct visualization of the complexes, which were analyzed with an
EMSA using non-reducing SDS-PAGE. Figure 3.23 presents the scan of the gel as an
overlay of blue (GFP) and green (Cy3) channels. Strong bands can be seen in the
upper part of the gel in the lanes 2-5. The position of the band in lane 5 in the scan
deviates from the other ones only due to gel wrapping on the edges during the scan
as these bands appear very close to the edge due to the large size of the complexes
and, hence, their very limited mobility. The first four lanes display also smeared Cy3
signal in the middle range, strongest for the highest SA concentration and no free
DNA can be observed there. The reference lanes of GFP and DNA are free of any
signal in the upper part of the gel.
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Optimization of the abovementioned approaches - although possible - was considered
too laborious and failure-prone, especially that an alternative solution has proven
successful. GFP carrying a short N-terminal ybbR tag for site-specific surface at-
tachment was employed instead [Yin et al., 2006].
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Figure 3.22: Covalent DNA-GFP complexes separated by native PAGE. a: Overlay
of blue (GFP) and green (DNA) channels displays a band representing successfully
formed complex (outlined in pink), b: green channel, c: blue channel; lane 1: GFP
+ DNA + DTT; lane 2: GFP + DTT control; lane 3: GFP + DNA + TCEP, lane
4: GFP + TCEP control; lane 5: DNA reference; lane 6: GFP reference.
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Figure 3.23: Covalent DNA-GFP complexes separated by non-reducing SDS-PAGE.
Overlay of blue (GFP) and green (Cy3-DNA) channels (each at 50 % transparence).
10-fold dilution series of maleimide-functionalized SA incubated with eGFP carrying
a terminal thiol group and with biotinylated, Cy3-labeled DNA, loaded along with
GFP and DNA references. A readout artifact appears in lane 8, however it does not
interfere with the bands. Complexes containing both GFP and DNA can be seen in
the lanes 2-5 (dilution factor 1-4) in the upper part of the gel. The apparent shifts in
bands’ positions are due to gel wrapping as the complexes barely enter the gel and
are not able to penetrate it further.
3.3 GFP-Nanobody binding strength determination 73
3.3.2 Molecular Force Balance measurements
The following section describes experiments performed together with another
PhD student, Daniela Aschenbrenner.
Here for the first time the Molecular Force Balance (described in section 1.1.3) was
adapted to probe protein-protein pairs. A single force balance consisted of the Nb-
GFP pair and an oligonucleotide duplex, as presented in Fig. 3.24. Two types of
GFP-binding Nanobodies were tested (for convenience later in this section referred
to as Enhancer and Modified Enhancer) against three GFP constructs: wild-type,
enhanced and superfolder GFP (sfGFP). The Nbs were immobilized on the glass
surface via a polymer linker and then GFP-DNA complexes were bound to them. A
complementary DNA strand was attached to the PDMS stamp. The stamp format
(4x4 patches) allows for analysis of 16 different MFBs in a single experiment. As
in the standard MFA, DNA oligonucleotides carried Cy3 and Cy5 labels allowing
fluorescence readout. The fluorescence of GFP was not essential for the evaluation
of the outcome but provided a convenient online control of sample quality. Indeed,
GFP fluorescence signal colocalized with that of Cy3 and Cy5, confirming the specific
interaction and correct assembly of protein force balances.
The surface density of the Protein MFBs estimated from the Cy5 signal was com-
parable to previous MFA experiments [Ho et al., 2009; Severin and Gaub, 2012],
about 104 MFBs per µm2. Since the relevance of the conclusions drawn from com-
parative measurements largely depends on maintaining all the measurement condi-
tions (including stamp pressure and loading rate), different constructs were analyzed
against each other only within a single stamping experiment.
Unlike for the model DNA-based MFA, adjusting the strength of the reference bonds
in case of protein-protein interactions was not that straightforward, as binding force
cannot be inferred simply from the structural data. For the sake of measurement
accuracy, however, it was crucial to keep the NF values as close as possible to 0.5,
which provides the best resolution. Therefore, reference DNA stability was tuned
using two approaches: intrinsic modification and by employing DNA-binding ligands.
DNA duplex integrity is largely affected by its base composition and relies mostly
on base stacking interactions aided by hydrogen bonds between complementary nu-
cleotides. The modified pyrimidines exploited here carried a 5’-propynyl group, ex-
tending into the major groove and enhancing base stacking. Altogether 13 cytidines
and 7 thymines of the biotinylated reference strand were modified. On the other
hand, three different sequence-specific polyamides were used to stabilize DNA in a
ligand-induced manner. Their binding to the minor groove of DNA was mediated
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by a pyrrole-imidazole hairpin. To ensure saturation of the DNA with polyamides,
they were used in 1 µM concentration, that is in about 1000-fold excess. The three
polyamides (denoted P1, P2 and P3) used here offered a range of affinities, with
KD values of 105 pM for P1, 44 pM for P2 and 1442 pM for P3 [Ho et al., 2009].
3.3.3 Binding strength of GFP-Enhancer vs. GFP-Modified
Enhancer
Binding strength was estimated based on the NF value. For all three references
(unmodified, propynyl-modified and with polyamide ligand) Modified Enhancer was
found to bind GFP stronger than Enhancer. The calculated NF values ranged from
0.2 to almost 1, depending on the type of GFP and reference (see Fig. 3.25). In
case of sfGFP, polyamide P1-bound 20 bp reference oligonucleotide provided the
best resolution with NF values for both Nanobodies falling in the optimal range
(around 0.5). Indeed, this example showed the largest spread between the two NF
values, while in other cases that difference was also observed, however not that
prominent.
All of the used DNA modifications resulted in duplex stabilization. The NF was
visibly reduced for 40 bp reference with propynyl bases and an even stronger ef-
fect was observed for polyamides, which were therefore applied in combination with
short, 20 bp, duplexes. Moreover, the stability enhancement by polyamides reflected
their affinity - P2 with lowest KD showed the strongest effect. P1 turned out to
be the perfect stabilizer for the Nb-GFP pair, shifting the NF values close to 0.5.
As expected, here also the largest spread between the two compared values could be
observed.
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Figure 3.24: Protein-protein Molecular Force Assay. A: schematic representation of
a single protein-protein MFB. B: schematic representation of the stamping procedure
consisting of MFA. Following molecular complexes assembly on the lower surface, the
stamp is lowered allowing biotinylated ends of DNA to bind to SA. During withdrawal
of the stamp, force builds up along each MFB until one of the bonds fails. After
stamping, the lower surface is scanned in the red and FRET channel to determine
the ratio of remaining surface bound molecules. Adapted from [Aschenbrenner et al.,
2014].
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Figure 3.25: Reference DNA modifications for adjustment of MFA sensitivity. A:
Reference types - unmodified DNA, intrinsically modified and ligand bound. B: Effect
of various reference DNA modifications on the sensitivity of MFA (here measuring
sfGFP). Largest spread in NF values was observed for the most balanced bond pair
(20 bp DNA + polyamide P1). Adapted from [Aschenbrenner et al., 2014].
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Figure 3.26: Analysis of different GFP variants for Enhancer interaction strength in
a Multiplexed Protein-MFA. Left: schematic representation of a single MFB consist-
ing of two bonds in series - the protein complex under study and a DNA duplex as a
reference (ribbon model structure of wtGFP (green) and Enhancer (magenta) based
on crystal structure from [30], PDB file 3K1K). Right: One example measurement
depicts the differences in binding strength of Enhancer tested against wild type, su-
perfolder, and enhanced GFP with the same reference DNA (20bp DNA stabilized
with polyamide P1). While eGFP and wtGFP bind to Enhancer with comparable
strength, binding of Enhancer to sfGFP is distinctively stronger. All data points are
determined in one single stamping process, derived as the mean of several protein
spots and displayed with standard deviation error bars. Adapted from [Aschenbren-
ner et al., 2014].
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3.3.4 Energy landscape of Nb-GFP complex
Some of the following experiments were performed together with another PhD stu-
dent, Philip Severin.
Here, Atomic Force Microscopy (AFM) was exploited to determine rupture forces of
the Nanobody and wild-type as well as enhanced GFP. The Nanobody-GFP complex
was probed with different pulling velocities ranging from 300 nm/s to 10 µm/s. The
most probable rupture force (F ) was obtained by fitting a Gaussian to the distribu-
tion of measured rupture forces and then plotted against the respective loading rate
(F˙ ). The linear two-state Bell-Evans model (see Eq. 1.12) was used to fit the data,
with koff - describing the dissociation rate at zero force - fixed at 1.45*10−4s−1 for
wtGFP [Kirchhofer et al., 2010] and 1.24*10−4s−1 for eGFP [Kubala et al., 2010].
Literature values of off-rates (koff ) were used for fitting since the covered range of
loading rates was not broad enough to determine the parameter with reasonable
accuracy.
We observed separate characteristic force regimes, as shown in Fig. 3.34. The
Nanobody bound to eGFP can withstand (within the applied loading rate range)
forces from 41- 56 pN, whereas in complex with wtGFP ruptures already at 28 -
45 pN. For increased clarity, the data are presented in this plot without error bars
(“width” in the force histograms). One should note that broad distribution of the
measured forces is intrinsic to the technique as it stems from thermal fluctuations
of the system (more significant at lower force range), and so does not diminish the
significance of its results. Linear dependence of force on logarithm of loading rate
suggested a single energy barrier along the reaction coordinate imposed by the di-
rection of the acting force. The obtained energy profiles are graphically presented in
Fig. 3.35.
Interestingly, we observed a 17 % broader barrier width for single-anchored wtGFP as
compared to eGFP, and an even broader one (by 49 %) for double-anchored wtGFP
(mean values of ∆x=1.36 nm for eGFP, ∆x=1.59 nm for single-anchored wtGFP
and ∆x =2.02 nm for double-anchored wtGFP). Using literature values of KD: 0.59
nM for eGFP-Nb [Kubala et al., 2010] and 1.4 nM for wtGFP-Nb [Kirchhofer et
al., 2010], we obtained binding free energies of -24.4 kBT for eGFP and -25.3 kBT
for wtGFP. Following Kramers theory [Kramers, 1940; Evans and Williams, 2002],
assuming an attempt frequency ν (describing passage of the energy barrier) of the
order of 107 results in
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koff = ν
∆G0
KBT (3.1)
koff ∼ 104, that is consistent with the known off rates of this complex.
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Figure 3.27: Results for a series of rupture force measurements obtained for
C-anchored eGFP in complex with the Nb.
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Figure 3.28: Results for a series of rupture force measurements obtained for
N-anchored eGFP in complex with the Nb.
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Figure 3.29: Results for a series of rupture force measurements obtained for
N+C-anchored eGFP in complex with the Nb.
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Figure 3.30: Results for a series of rupture force measurements obtained for
C-anchored wtGFP in complex with the Nb. (Fig.: P. Severin)
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Figure 3.31: Results for a series of rupture force measurements obtained for
N-anchored wtGFP (cantilever a) in complex with the Nb.
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Figure 3.32: Results for a series of rupture force measurements obtained for
N-anchored eGFP (cantilever b) in complex with the Nb.
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Figure 3.33: Results for a series of rupture force measurements obtained for
N+C-anchored eGFP in complex with the Nb.
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Figure 3.34: Dynamic force spectrum of Nb-GFP complexes obtained based on
pulling velocities ranging from 300 nm/s to 10000 nm/s. Data points for eGFP
are shown with square markers and wtGFP with circle ones; solid markers denote
single-anchored GFP (N- or C-terminally) and open ones double-anchored GFP.
Data were fitted to the Bell-Evans model using literature off-rate values for wtGFP
(koff = 1.45 ∗ 10−4s−1) [Kirchhofer et al., 2010] and eGFP (koff = 1.24 ∗ 10−4s−1)
[Kubala et al., 2010].
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Figure 3.35: Energy profile of the Nb-GFP complex along the direction imposed by
the pulling force. The energy barrier appears 17 % shifted: from 1.36 nm (eGFP)
to 1.59 nm (single-anchored wtGFP), and even further to 2.02 nm (i.e. by 49 %) for
double-anchored wtGFP.
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3.3.5 Specificity control in Nb-GFP force spectroscopy
To exclude the possibility of force spectroscopy outcome resulting from nonspecific
interactions between the cantilever and the sample surface, we performed measure-
ments on several constellations of cantilever-surface pairs, where one or both of the
interacting partners were missing or inactivated. The objective was to compare the
picking efficiencies with those of properly prepared samples. The results are pre-
sented in Table 3.1.
Schematic
representation
of the set-up
Set-up and retract
speed
curves
total
curves
selected peaks
peak
ratio
Experimental set-up
1 m/s 434 226 226 52.1 %
Nb excess
1 m/s 1024 7 7 0.7 %
Nb excess
5.88 m/s 1011 36 35 3.5 %
GFP excess
1 m/s 1001 51 51 5.1 %
GFP excess
5.88 m/s 1101 59 59 5.4 %
no Nb
0.798 m/s 1033 35 2 0.3 %
no Nb
4 m/s 1661 53 7 0.4 %
Table 3.1: Negative control experiments. Comparison of interaction ratios for a
typical experimental set-up, one of the interaction partners blocked or missing.

Chapter 4
Discussion
4.1 Streptavidin-biotin bond strength
The well-known and widely used receptor-ligand pair of streptavidin and biotin has
already been broadly described by others but available data are not unanimous
[Moy et al., 1994; Allen et al., 1996; Wong et al., 1998; Yuan et al., 2000; Lo et
al., 2001; Stevens et al., 2002]. Previous AFM approaches (cited above) relied on
a statistical interpretation of a series of peaks in the obtained force distribution.
The primary peak was attributed to the single-molecule events, and the following
ones to multiple ruptures. While such explanation is obviously reasonable, it does
not exclude the bias caused by unspecific interactions or values accidentally falling
in the range of interest. Here, the rupture force of the complex was characterized by
AFM force spectroscopy using the fingerprint provided by the DNA spacer, which
ensured that only single-molecule events were analyzed to determine the strength of
the interaction. It is of particular importance due to the multivalency of the protein
- since a single (tetrameric) SA moiety can accommodate up to four biotins. This
allowed to determine the most probable rupture force characterizing the biotin-SA
complex as 165.6 ± 3.1 pN. Since values reported in the literature vary greatly and
at the same time in most cases the applied loading rates (a parameter significantly
affecting the measured force) are not stated, it is not possible to directly compare
these results.
Apart from the main peak, the force histogram features also a shoulder towards
higher values, which can be explained based on the experiment’s geometry. The
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tetramers of SA were attached to the cantilever in a random orientation via intrinsic,
surface exposed amines. Therefore, of the four biotin-binding pockets of each SA
moiety, some were easier accessible (pointing towards the slide surface) than others.
However, binding took place with the DNA in a relaxed form and so also the hidden
pockets could be approached by the biotinylated end of the DNA. In such case, the
DNA stretching and biotin unbinding proceeded along different directions, therefore
a higher force was necessary to rupture the biotin-SA complex.
It should be noted here that the measured force value falls into the regime char-
acteristic of force-induced dsDNA melting [Clausen-Schaumann et al., 2000], which
may bias the obtained result. Additional measurements involving stabilized DNA
duplex (by DNA binders) could help discriminate between strand separation and
protein-ligand dissociation. Yet these pilot experiments have proven the feasibility
of the assay to access single molecules and further investigate other biomolecular
interactions.
4.2 MeCP2-DNA interaction
MeCP2 interaction with methylated DNA has been subjected to extensive studies
employing two powerful single-molecule techniques: AFM and MT. We were inter-
ested in investigating the phenomenon of DNA loop formation upon MeCP2 binding
to methylated CpG sites as suggested in [Ghosh et al., 2010a]. In case of both tech-
niques, MeCP2-stabilized loops should result in the shortening of the contour length
of the stretched DNA molecule.
Surface density of DNA depends on a number of factors, including reactivity of the
functional groups of the slide and DNA, age of the slides or air exposure prior to use
or concentration of the applied DNA. From our experience, even strictly following the
preparation procedure does not guarantee reproducible sample quality. Aware of the
abovementioned issues, prior to force spectroscopy measurements we performed an
EMSA test with a sole purpose of proving MeCP2 ability to bind to the methylated
DNA. Band shifts observed in lane 2 and 3 in Fig. 3.3 provide a clear evidence for
that, and the shift is more pronounced for higher protein concentration as diluted
MeCP2 does not saturate the available binding sites. Since, regarding the AFM
samples, it was not possible to determine the exact amount of the DNA bound to
the surface, no conclusions regarding stoichiometry would anyway be relevant to the
AFM experiment.
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The possibility of single-molecule control was central to the experimental design
allowing for the detection of MeCP2-induced loop formation. Based on the current
state of the research, it is not clear whether the observed looping is stabilized by
a single MeCP2 binding to more than one site on the DNA (often referred to as
"sandwich" formation) [Georgel et al., 2003; Nikitina et al., 2007] or whether the
loops form through dimerization or oligomerization of the protein [Ghosh et al.,
2010a]. DNA-bound oligomers have been observed in vitro [Georgel et al., 2003] and
in vivo [Brero et al., 2005], however Klose and Bird [2004] and Adams et al. [2007]
challenged their existence before Becker et al. [2013] confirmed the phenomenon and
mapped the region of MeCP2 mediating the contact between proteins. Regardless
of the actual mode of action, the primary goal of the experiments presented in this
thesis was to detect DNA looping by MeCP2 with a single-molecule resolution.
In the first, naïve approach, 1 kb long DNA with 35 methylated CpG sites was used,
offering a multitude of loop sizes. The positions and nucleotide context of all the CpG
sites are presented in Table 4.1. Upon MeCP2 binding, compaction of the DNA was
expected and subsequent stepwise rupture as the ends of the molecule were pulled
apart. Indeed, the characteristic B-S fingerprint in the force curves was completely
lost upon addition of the protein. The high force peak ("hump") observed in the
presence of MeCP2 indicated its interaction with the probed DNA but the ruptures
could not be resolved down to single molecule events. Here the issue of surface density
came to play; to ensure high picking efficiency, a relatively high density of molecules
on the surface was desired, while that translated into shorter molecule-to-molecule
distances and increased probability of intermolecular cross-links to occur. Further-
more, multiple intermolecular connections could be attributed to the high density of
CpG sites within each DNA molecule. Hence, even probing a single molecule led to
pulling a whole net of entangled and interconnected strands.
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CpG position nucleotide context
78 TTATCAAAAGCGGGAAGAATAC
96 ATACATTCATCGATAGTAGATG
110 AGTAGATGGACGATATTTCTGT
195 TTATAAAGGCCGAAGCCCTCTA
215 TATTAAAAATCGTGGGTAGAAT
252 CCACATAATTCGCGTGTTCACC
254 ACATAATTCGCGTGTTCACCTT
409 ATATTTAACACGGGTCAGAGCA
443 TTATTAAAACCGTTAATTACGA
452 CCGTTAATTACGATTTTACCTT
471 CTTCTTTTACCGTGATAGCAAT
502 TTGCAGACCACGAGATACACGC
511 ACGAGATACACGCAACAGCTGT
564 CAGATGCTACCGGGAATGGAAT
603 CTACTGTACTCGGATCGGCTGC
608 GTACTCGGATCGGCTGCTGGCC
634 AATTGTTGAGCGGGCATCAGCA
710 GACAGAATACCGAGAAAACCGT
719 CCGAGAAAACCGTTCAAATCGT
728 CCGTTCAAATCGTAAATTGCTA
755 AAATCAATAACGTCAGAAATAT
755 TATTTGCTTCCGCATAAGTTGT
774 CCATTAACTGCGCGAGTCATAA
797 ATTAACTGCGCGAGTCATAATA
799 ATAAATTGACCGGATTTAAGCA
851 TTAATAGTAGCGAAATTTTTAA
953 AAGCAATTAACGATTAAAATCA
967 TAAAATCAGCCGCAATTGTTTC
979 CAATTGTTTCCGCAACAATTTG
1007 AACAATTAGACGTTCATCTGCA
1023 TCTGCATTACCGCAATAATCAT
1043 ATCTTCAAGGCGTTCACCACAT
1077 AATTTAGCACCGGCGTTTAGGG
1080 TTAGCACCGGCGTTTAGGGATT
1106 AGTATGTTTGCGCATTAGTTCA
Table 4.1: Nucleotide context of all 35 CpG sites of 1.1 kb DNA fragment
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To gain a better control over the behavior of the pulled strands, we used an in
vitro methylated DNA construct (otherwise identical with the fully methylated one)
with two or three methylated CpG sites, limiting the possible strand shortening dis-
tances caused by intramolecular looping. The two methylated sites were separated
from each other by 309 bp, that is a distance corresponding to double the persis-
tence length of dsDNA. In the other methylation pattern, the distances between the
MeCP2 binding sites were 250 bp or 500 bp. Contrary to the expected data quality
improvement - since much less interactions were allowed and the set of predicted
shortening lengths was discrete - addition of MeCP2 resulted in a similar high force
peak as previously.
However, interesting findings followed one particular AFM experiment, in which -
when pulling a fully methylated DNA - the "step" pattern was observed during can-
tilever retraction. The unusually shaped curves were recorded for hand-controlled
cantilever actuation aimed at much more gentle agitation than the automated pro-
cedure. The most likely explanation of the observed "steps" assumes two nicks
on the opposite strands of one DNA molecule, in a close distance from each other,
which upon DNA stretching and shearing would lead to eventual rupture of a double-
stranded piece of DNA leaving it attached to the cantilever as schematically presented
in Fig. 4.1. Subsequent surface probing resulted in multiple cross-links between the
DNA coupled to the cantilever and that on the surface. The overall good quality of
the DNA used in the described force spectroscopy experiments explains the rarity of
the described observation.
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Figure 4.1: Schematic explanation of the observed "step"-pattern in force curves
of DNA stretched in presence of MeCP2. The experiment assumes stretching sin-
gle dsDNA molecules. However, nicks present relatively close to each other on the
opposite strands of a DNA molecule result in breaking of the molecule, leaving a
dsDNA fragment permanently attached to the cantilever. Subsequently, this frag-
ment probes the surface creating multiple cross-links with DNA on the surface. Each
"step" in the force curve represents a single rupture of one such cross-link, leading
to a slight increase in the current contour length of the tether. For a short while the
system regains flexibility, which is reflected in the increase of force before the next
step occurs.
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Taking the outcome of the "steps" analysis as a hint, we decided to reach out for
another SM technique capable of overcoming the surface density problem encountered
with AFM, namely magnetic tweezers (MT). Our first MT experiments were designed
so as to reproduce the conditions of the AFM ones and explain the "step" pattern
observed there. For this reason, the same 1.1 kb DNA fragment was incorporated
into the 5-kb-long MT tether and 1x PBS was used as assay buffer. Since the
initial MT trials with 300-bp-loop DNA did not yield any positive results regarding
loop detection, we moved on to optimize the assay. First, the loop was extended
to 600 bp, then experimental conditions were adjusted to match the optimum for
MeCP2. Various reported in literature aspects improving MeCP2 affinity were tested,
including high salt conditions [Ghosh et al., 2010a] or stretches of A/T nucleotides
adjacent to the binding site [Klose et al., 2005] known to cause DNA bending and
widening of the major groove [Ho et al., 2008]. None of these changes brought
any improvement to our understanding of the MeCP2-DNA interaction. Both the
600 bp loop DNA and 1.1 kb methylated DNA ruled out the possibility of DNA
stiffness being the limiting factor in loop forming. It is important to mention here
the statistical background of reasoning in SM techniques. The analysis in both the
abovementioned cases (AFM or MT) relies on a very limited (often to single digits)
number of molecules picked from a huge batch - be it a few molecules displayed
on the cantilever or a few tethers analyzed within an MT experiment. Therefore,
proper sample preparation and ensuring its homogeneity as well as high quality is
of paramount importance. We controlled the efficiency of enzymatic methylation by
subsequent digestion of not fully methylated DNA, so that only properly prepared
molecules were applied on the surface.
Strangely, MeCP2 action was clearly apparent in AFM experiments but remained
undetectable in all the MT trials. The only significant difference in screening pro-
cedure was the waiting time between protein application onto the surface and the
measurement itself, which was much longer (about 20 minutes) in case of AFM mea-
surements and just a few minutes in MT. However, since keeping the tethers relaxed
at low force for a longer time usually results in an inevitable loss of beads sticking
to the flowcell surface, matching this condition was not considered here. This could
well be the reason for the lack of loops observed when using the MT technique. A
way to test the time requirements characterizing the MeCP2 action on the DNA
could be another AFM trial with respectively short equilibration time. On the other
hand, the differences in signal detection between these two techniques justify the ap-
plied conditions. AFM readout could suffer from too much noise to draw meaningful
conclusions.
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The satellite peaks recorded for low force traces in Fig. 3.15 a) illustrate the vul-
nerability of SM measurements to minute contaminants, which - although rare - do
occur (e.g. airborne dust). The other two graphs analysing that set of data (Figures
3.14 a) and 3.16 a) with single peaks centered at 0) confirm stability of the tethers’
lengths throughout the blank measurement.
Although MeCP2-stabilized loops were imaged in previous works by EM and AFM
[Georgel et al., 2003; Nikitina et al., 2007; Ghosh et al., 2010a], recording the process
of their formation remains a challenge. A possible explanation for no change in tether
behavior upon the addition of the protein could be its unspecific attachment at a
second site (by one of its methylation-independent domains as described in 1.5.2,
leading to sliding of MeCP2 along the DNA, not detectable with the resolution of
the applied techniques. It is common for DNA-binding proteins to bind weakly to an
unspecific site and then search for the specific one. This is accomplished by either
sliding along the DNA or hopping (referred to as "intersegmental transfer") to more
distant places on the same or sometimes also another molecule [Halford and Marko,
2004]. Such mechanism increases the effectiveness of finding the specific binding
sites. Indeed, MeCP2 possesses a number of domains capable of unspecific DNA
binding: intervening domain (ID), transcription repression domain TRD, C-terminal
domain α (CTD-α)[Ghosh et al., 2010b; Kumar et al., 2008]. On the other hand, the
overall positive charge of MeCP2, resulting in unspecific binding to the negatively
charged DNA backbone [Stuss et al., 2013] could underlie the hump observed in the
AFM experiments.
Finally, having tested the MT set-up using EcoRII in the exact same conditions
against its capability of loop detection, we showed that it is definitely suited for that
purpose, yet the MeCP2-DNA interaction needs to be approached differently - how
exactly remains beyond the scope of this work. We decided to leave the preliminary
results as a starting point for other studies.
4.3 GFP-Nb
Another biomolecular complex we tried to understand on a single-molecule level was
the GFP-Nanobody pair. We chose three different subtypes from the rich repertoire
of GFPs: wild-type, enhanced and superfolder GFP (wtGFP, eGFP and sfGFP).
The Nb family was represented by one GFP binder (referred to as Enhancer) and its
modified form (Modified Enhancer) harboring an additional N-terminal peptide tag.
Growing interest in single-molecule manipulation and analysis motivated this study
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as detailed understanding of the intermolecular phenomena can not be accomplished
based solely on ensemble averaged data from bulk measurements.
4.3.1 Nb-GFP interface
GFP has a structure of a β-barrel with both its N- and C-terminus protruding from
the same side of its 3D structure. This enables GFP anchoring to the surface via
either one of its termini as well as via both simultaneously, keeping its orientation
unchanged. Moreover, upon GFP immobilization, the epitope recognized by the
Nanobody is exposed, as it is located on the opposite side of the β-barrel. Similarly,
anchoring the Nanobody to the solid support via its C-terminus, should leave its
binding site unaffected. Accessibility of the epitope is a prerequisite for efficient
single molecule probing of specific interactions, which should not be hindered by
unfavorable attachment to the solid support.
Each of the three compatibility-determining regions (CDRs) of the Nanobody con-
tribute to its binding to GFP, accomplished mostly by electrostatic interactions and
a single hydrophobic contact. The epitope extends over 672 Å2 at the exposed loop
region between the strands 6 and 7 of the GFP β-barrel [Kirchhofer et al., 2010].
Site-specific protein attachment provides a controlled and uniform probing geometry,
which is crucial for the correct interpretation of the obtained results. In case of
protein anchoring utilizing maleimide-thiol chemistry, it is important to ensure that
the attachment results solely from the engineered cysteine coupling to surface and
that no protein-intrinsic cysteine reacts with maleimide. In its native state, GFP
contains two reduced cysteines at positions 48 and 70. Cys70 is buried inside the
β-barrel, while Cys48 is partially solvent exposed. However, it is not available for
binding to maleimide on the surface, which I tested using unmodified GFP according
to a standard surface preparation procedure (data not shown). This proved that
coupling of GFP was site-specific as desired.
4.3.2 MFB results
The Molecular Force Balance (MFB) has proven successful in various comparative
studies of molecular interactions [Albrecht et al., 2003; Severin et al., 2011; Limmer et
al., 2014; Ho et al., 2009]. So far it was, however, limited to DNA samples - much less
demanding in terms of experimental conditions and handling. Here, the applicability
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of this versatile method was expanded over the vast world of interactions involving
proteins. Due to the strict and narrow tolerance characteristic to most proteins, a
number of adjustments had to be implemented to ensure integrity and reliability of
the assay.
The MFB utilizes the principle of two bonds in series probed simultaneously until,
statistically, the weaker one breaks. Therefore, covalently-linked hybrids of protein
and DNA were crucial to the functionality of the comparative force assay, thanks
to which only the reference or the test bond were in question when under load.
The GPF-DNA complexes were formed by reacting the ybbR tag to CoA-derivatized
DNA strand as in [Pippig et al., 2014], which turned out to work efficiently.
The GFP-Nb complexes outlived 40 bp DNA in the shear geometry, indicating it
can withstand forces of at least 65 pN. No distinction in binding force was observed
between eGFP-Nb pair (NF=0.255 ± 0.023) and wtGFP-Nb pair (NF=0.253 ±
0.018), while the NF factor of sfGFP was significantly higher (0.353 ± 0.018). This
difference in binding strength can be attributed to the substitutions of five amino
acids - two directly contacting the Nanobody and three maintaining hydrophobic
interactions. The epitopes of eGFP and wtGFP do not display any differences.
Figure 4.2 presents the alignment of all three GFP sequences with highlighted amino
acids making up the Nb-binding epitope.
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Figure 4.2: Alignment of GFP constructs used in MFB. From: [Aschenbrenner et
al., 2014]
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Consistently throughout all the MFB measurements, all GFP variants bind stronger
to the modified GFP binder than to its "bare" version. This difference can be
explained by a difference in isoelectric points of the two Nanobodies, despite their
identical epitopes (pI=7.85 in case of the proper GFP binder compared to pI=9.89
for the modified one). Moreover, we were able to demonstrate a lot of flexibility
in fine-tuning of the balance by the use of DNA binding ligands. These visibly
altered the rupture force characteristic to the DNA oligonucleotides by stabilizing
the double-stranded DNA structure. Hence, the sensitivity of the balance could
be conveniently set to its maximum - that is around the equilibrium point (where
NF=0.5). Importantly, modification of the reference (DNA) bond does not influence
the Nb-GFP complex, and so for all the different experimental conditions for a given
GFP variant, the relation between the binding strengths of the two Nb variants
remained unchanged.
The example of DNA modifiers presented here demonstrate the possibility of tuning
the sensing capacity of MFB in a broad range. Other ways of DNA stability modu-
lation could also be considered regarding reference bonds, e.g. oligonucleotide-linked
polyamide strands [Ryabinin et al., 2004] or tethered major groove amines [Szulik et
al., 2013].
4.3.3 AFM results
Intuitively, one could expect a difference in rupture force between single- and double-
anchored GFPs. Single attachment point offers much more flexibility for the protein
complex to spatially orientate along the acting force, while fixing the GFP at both
termini restricts its freedom of movement the more the complex extends. The stiffer
two-point attachment should then result in GFP β-barrel held rather vertically upon
extension and the Nanobody "peeling off" or sliding from the side of GFP. Indeed,
data for wtGFP prove this concept. In single-anchored GFP pulling by Nb, the whole
interaction interface of the complex aligned along the pulling direction experiences
the rupture at once. Contact between the two protein surfaces is rapidly lost, hence
the smaller potential width (∆x). In case of double-anchored GFP, gradual loss of
contact between the Nb and its epitope manifests itself with broader potential width
and lower force. This distinction however does not apply to the eGFP constructs,
which withstand higher forces when pulled on in complex with Nb - high enough
to unfold the N-terminal α-helix, which occurs at around 35 pN and contributes
additional 2.9 nm to the effective spacer length [Dietz and Rief, 2004]. Hence, the
complex - although double-anchored - effectively experiences only a single (shorter)
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anchor and behaves accordingly in response to stretching. The alignment of the
GFP constructs used in the AFM measurements (based on DNA sequencing results)
is presented in Fig. 4.3.
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  1       10        20        30        40        50        
NCwtGFP     KGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWP....                                                        
NwtGFP     KGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWP....                                                        
CwtGFP     KGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWP..MG                                                        
NeGFP      KGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPMACS                                                        
NCeGFP     KGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWP.MVS                                                        
CeGFP      KGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWP.MVS                                                        
60        70        80        90       100       110        
NCwtGFP TLVTT  YGVQCFSRYPDHMK HDFFKSAMPEGYVQERTI FKDDGNYKTRAEVKFEGDT     S                                                   F R S
NwtGFP TLVTT  YGVQCFSRYPDHMK HDFFKSAMPEGYVQERTI FKDDGNYKTRAEVKFEGDT     S                                                   F R S
CwtGFP TLVTT  YGVQCFSRYPDHMK HDFFKSAMPEGYVQERTI FKDDGNYKTRAEVKFEGDT     S                                                   F R S
NeGFP  TLVTT  YGVQCFSRYPDHMK HDFFKSAMPEGYVQERTI FKDDGNYKTRAEVKFEGDT     T                                                   L Q F
NCeGFP TLVTT  YGVQCFSRYPDHMK HDFFKSAMPEGYVQERTI FKDDGNYKTRAEVKFEGDT     T                                                   L Q F
CeGFP  TLVTT  YGVQCFSRYPDHMK HDFFKSAMPEGYVQERTI FKDDGNYKTRAEVKFEGDT     T                                                   L Q F
120       130       140       150       160       170        
NCwtGFP LVNRIELKGIDFKEDGNILGHKL YNYNSHNVYI ADKQKNGIK NFKIRHNIEDGSVQL                                          A               Q T
NwtGFP LVNRIELKGIDFKEDGNILGHKL YNYNSHNVYI ADKQKNGIK NFKIRHNIEDGSVQL                                          A               Q T
CwtGFP LVNRIELKGIDFKEDGNILGHKL YNYNSHNVYI ADKQKNGIK NFKIRHNIEDGSVQL                                          A               E T
NeGFP  LVNRIELKGIDFKEDGNILGHKL YNYNSHNVYI ADKQKNGIK NFKIRHNIEDGSVQL                                          V               E M
NCeGFP LVNRIELKGIDFKEDGNILGHKL YNYNSHNVYI ADKQKNGIK NFKIRHNIEDGSVQL                                          V               E M
CeGFP  LVNRIELKGIDFKEDGNILGHKL YNYNSHNVYI ADKQKNGIK NFKIRHNIEDGSVQL                                          V               E M
180       190       200       210       220       230        
NCwtGFP ADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGIT GMDELYK                                                    H       
NwtGFP ADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGIT GMDELYK                                                    H       
CwtGFP ADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGIT GMDELYK                                                    H       
NeGFP  ADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGIT GMDELYK                                                    L       
NCeGFP ADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGIT GMDELYK                                                    L       
CeGFP  ADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGIT GMDELYK                                                    L       
                                                            
NCwtGFP ........                                                    
NwtGFP ........                                                    
CwtGFP L.......                                                    
NeGFP  GHHHHHH.                                                    
NCeGFP G.......                                                    
CeGFP  GHHHHHHC                                                    
Orange dots indicate residues involved in direct contact with the Nanobody.
Figure 4.3: Alignment of GFP constructs used in AFM. Orange dots indicate residues
in direct contact with the Nanobody; highlighted in orange are the ones conserved
in all the measured GFP constructs. Two of the wtGFP constructs display a muta-
tion in one contact site (highlighted in turquoise). Alignment was performed using
ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
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4.3.4 Specificity of interactions in AFM
In force measurements it is crucial to discriminate specific from unspecific interactions
to reduce the impact on the analysis by the latter. In protein unfolding studies this is
often accomplished by including an extra domain in the construct, which unfolds at
lower force than the protein of interest, yielding a fingerprint in the force-extension
curves. The relatively low rupture forces measured for the Nb-GFP complex pose
a difficulty in finding a compatible protein signature for this purpose. Therefore
we analyzed a number of negative control experiments where binding sites on the
Nanobody or GFP were blocked with an excess of the respective binding partner as
well as measurements utilizing incompletely functionalized (i.e. lacking the protein)
cantilevers or surfaces. In all cases the interaction frequency was drastically reduced
as compared to specific Nb-GFP probing.
4.4 Importance of single-molecule studies of protein
complexes
In response to the emergence of protein-based single-molecule manipulation tech-
niques, mechanistic analysis of the Nb-GFP interaction bridges the gap between
available bulk-derived affinity data and relevant to single molecule force character-
istic describing an isolated complex. The fact that the measured forces are in the
range of DNA oligonucleotides unbinding [Schumakovitch et al., 2002] makes the
Nb-GFP complex a promising candidate as a reference in protein-based comparative
force assays. This indicates the applicability of the Nb-GFP complex in determin-
ing strength of yet uncharacterized protein pairs. Furthermore, one can imagine
the application of Nanobodies as molecular force sensors also in vivo - a currently
challenging and much desired research direction [Cost et al., 2015].
Single-molecule techniques broaden the horizon of interactions available for identi-
fication and detailed investigation, by including the less tight or less stable ones.
Weak protein-protein interactions are found particularly among signaling cascades
and regulatory pathways [Bhattacharyya et al., 2006; Stein et al., 2009; Bashor et
al., 2010]. Characterized by definition by lower stability, they are often missed by
classical approaches [Rudolph, 2007; Ohlson, 2008]. Many of them are responsible
for the dynamics of intracellular molecular environment and the transient nature re-
flects their function - after signal propagation the complex dissociates into its stable
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constituents. The importance of transient interactions lies in their potential as drug
targets, like for instance nutlins used in cancer therapy, stabilizing tumor suppressor
p53 [Vassilev et al., 2004] or colchicine stabilizing the dimers of α- and β-tubulin and
blocking their polymerization [Ravelli et al., 2004].
4.5 Summary
This work presents examples of the complexity of biomolecular interactions and
points out a number of limitations of particular techniques in regard of explaining
the mechanisms underlying the subtle differences, which make an approach suitable
for one system not necessarily transferrable to another one. Different single-molecule
techniques complement each other in their applicability to investigate various
biological complexes. Yet very often finding the right approach is not a trivial
task.
4.6 Outlook
Given the recent advances in the field of single-molecule manipulation, the Nb-GFP
complex offers great opportunities for further expansion, e.g. in the cut-and-paste
technology [Kufer et al., 2008]. Direct follow-up experiments at this point could
include identifying three different types of Nanobodies suited as handles to immo-
bilize, pick up and deposit elsewhere GFP-tagged proteins. Based on the findings
presented in [Kirchhofer et al., 2010], one of the two steps of this GFP takeover could
be realized by the pair referred to as Minimizer and Enhancer in the abovementioned
publication, since these two binders display such a hierarchical behavior. Thanks to
the popularity of the GFP-tag, most proteins have already been fused to the GFP,
which makes this strategy straightforward and ready to use once such a GFP-binder
based system has been established.
Appendix A
List of abbreviations
◦ 3D - 3-dimensional
◦ 5hmC - 5-hydroxymethylcytosine
◦ Å - Ångstrom
◦ AFM - Atomic Force Microscope
◦ bp - basepair
◦ BG - benzylguanine
◦ CDR - Complementarity Determining Region
◦ CE - coupling efficiency
◦ CoA - Coenzyme A
◦ Co-IP - Co-Immunoprecipitation
◦ CpG - C-phosphate-G
◦ dCTP - deoxycytidine triphosphate
◦ ddH2O - double-distilled water
◦ DMF - dimethylformamide
◦ DNA - deoxyribonucleic acid
◦ dsDNA - double-stranded deoxyribonucleic acid
◦ dNTP - deoxynucleotide
◦ EDC - 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
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◦ dUTP - deoxyuridine triphosphate
◦ eGFP - enhanced Green Fluorescence Protein
◦ EMSA - Electrophoretic Mobility Shift Assay
◦ Fab - Fragment, antigen-binding
◦ FJC - Freely Jointed Chain
◦ fN - femtonewton
◦ FRET - Fluorescence Resonance Energy Transfer
◦ GA - Gibson Assembly
◦ GFP - Green Fluorescence Protein
◦ h - hour
◦ hAGT - human O6-alkylguanine-DNA alkyl transferase
◦ HCAb - heavy-chain-only antibody
◦ HisTag - polyhistidine-tag
◦ Ig - immunoglobulin
◦ kB - Boltzmann constant
◦ Kd - dissociation constant
◦ kb - kilobase
◦ kDa - kilodalton
◦ LB - lysogeny broth
◦ MBD - Methyl-DNA Binding Domain
◦ MeCP2- methyl CpG binding protein 2
◦ MFA - Molecular Force Assay
◦ MFB - Molecular Force Balance
◦ min - minute
◦ mm - millimeter
◦ mM - millimolar
◦ MT - Magnetic Tweezers
◦ µl - microliter
◦ µM - micromolar
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◦ NA - Neutravidin
◦ Nb - Nanobody
◦ NF - normalization factor
◦ NHS - N-hydroxysuccinimide
◦ nm - nanometer
◦ NMR - Nuclear Magnetic Resonance
◦ PAGE - Polyacrylamide Gel Electrophoresis
◦ PBS - Phosphate-buffered saline
◦ PCR - Polymerase Chain Reaction
◦ PDMS - polydimethylsiloxane
◦ PEG - Polyethylene Glycol
◦ PMSF - phenylmethanesulfonyl fluoride
◦ pN - piconewton
◦ RNA - Ribonucleic acid
◦ RTT - Rett Syndrome
◦ s - second
◦ SA - streptavidin
◦ sfGFP - superfolder Green Fluorescence Protein
◦ SFP - 4´-phosphopantetheinyl transferase
◦ SM - Single-Molecule
◦ TCEP - tris(2-carboxyethyl)phosphine
◦ UHRF1 - Ubiquitin-like containing PHD and RING finger domains 1
◦ UV - ultraviolet
◦ v/v - volume/volume
◦ WDR - WW domain-binding region
◦ WLC - Wormlike Chain
◦ wtGFP - wild-type Green Fluorescence Protein
◦ Y2H - Yeast Two-Hybrid
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